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Abstract 
 
Abstract 
 
Autophagy is an intracellular bulk degradation process of cytoplasmic proteins and 
organelles aimed to preserve cellular homeostasis. It involves the formation of 
double-membrane structures, called autophagosomes that transport their cargo to 
the lysosomes where it becomes degraded. The molecular mechanisms underlying 
induction of autophagy, biogenesis, trafficking and turnover of autophagosomes 
have been extensively studied. However, the regulation of these steps by signaling 
pathways that adjust the autophagy flux to different cellular stress situations is still 
poorly understood. The aim of this work was to investigate the regulation of 
autophagy upon particular stress conditions in a time-dependent manner. We 
particularly focused on the control of autophagy by p38. For this purpose we applied 
a MCF-7/NeuT cell model of oncogene-induced senescence (OIS). In this model, 
doxycycline-inducible expression of an oncogenic variant of ERBB2 (NeuT) in the 
breast cancer cell line MCF-7 leads to premature senescence, a process that was 
shown to be accompanied by aberrant accumulation of autophagic vesicles. We 
found that autophagy becomes initially induced but that its maturation is later 
impaired upon oncogenic stress. In addition we identified p38/MAPK as the signaling 
pathway mediating the block of  autophagic flux. This was evidenced by the fact that 
pharmacological inhibition of p38 by the small molecule compound SB203580 can 
restore the autophagic flux. This result was confirmed in time-dependent rescue 
experiments with SB203580. Furthermore, mechanisms by which p38 mediates the 
autophagic flux blockade were identified. These involved post-translational 
modifications of the microtubule-associated proteins MAP4 and OP18/STMN1, as 
well as down regulation of a particular dynein motor protein subunit DYNLL1, which 
all together provoke microtubule disruption and defective autophagosome transport 
to the lysosome. The biphasic behaviour of autophagy upon stress (early induction, 
late block) was confirmed in several cell lines exposed to a different stress-stimulus 
(anisomycin). Here we could show that also p38/MAPK is involved in these effects in 
a dual way, with an early induction of initial steps of autophagy and a later block of 
maturation. In addition, the p38-mediated block of the autophagic maturation was 
shown to occur via the same mechanism described above.  
 
Abstract 
 
 
In conclusion, this work revealed new aspects of the control of autophagy by p38 
signaling, mainly that the duration and intensity of p38 activation are key 
determinants of the autophagic flux rate. Low or transitory stress conditions that 
moderately activate p38 stimulate the autophagic flux. In contrast, more permanent 
and intensive stress that causes a strong activation of p38 blocks the autophagic 
flux. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Zusammenfassung 
 
Autophagie ist ein intrazellularer Prozess zum Abbau cytosolischer Proteine und 
Organellen, denen als Hauptrolle die Aufrechterhaltung der zellulären Homöostase 
zugeschrieben wird. Bei diesem Vorgang werden Doppelmembran-Strukturen 
gebildet, Autophagosomen, welche ihr eingeschlossenes Material dem lysosomalen 
Abbau zuführen. Die molekularen Mechanismen, welche Initiation der Autophagie, 
Biogenese, Transport und Abbau von Autophagosomen zugrunde liegen, sind 
weitgehend untersucht. Wie Signaltransduktionswege der Zelle diese Schritte 
regulieren, um den Autophagiefluss an verschiedenen Stress-Bedingungen 
anzupassen, ist allerdings ungenügend verstanden. Ziel dieser Arbeit war, die 
zeitabhängige Regulation der Autophagie unter verschiedenen Stressbedingungen 
zu untersuchen. Der Schwerpunkt lag in der Erforschung der Steuerung durch P38. 
Zu diesem Zweck wurde ein Zellmodel der Onkogen-vermittelten Seneszenz, das 
MCF-7/NeuT Zellsystem, verwendet. In diesem Model führt die Doxyzyklin-
abhängige Expression einer onkogenen Variante von ERBB2 (NeuT) in der 
Brustkrebszelllinie MCF-7 zu einer verfrühten Seneszenz, ein Zustand der eine 
dramatische Akkumulation von autophagischen Vakuolen aufweist. Im Rahmen 
dieser Dissertation wurde gezeigt, dass unter onkogenem Stress die Autophagie 
zunächst induziert, jedoch in einer späteren Phase blockiert wird. Darüber hinaus 
konnte durch pharmakologische Inhibition von p38 mit dem small molecule 
SB203580 gezeigt werden, dass der p38/MAPK Signalweg die Blockade des 
Autophagieflusses vermittelt. Des Weiteren wurden Mechanismen aufgeklärt, die für 
den p38-vermittelten Autophagie-Block verantwortlich sind. Dabei konnten post-
translationale Modifikationen der Mikrotubuli-assoziierten Proteine MAP4 und 
OP18/STMN1, sowie die Herunterrergulierung der Dynein Untereinheit DYNLL1 mit 
P38 in Verbindung gebracht werden. Diese Ereignisse führen zu einer 
Destabilisierung des Zytoskeletts und einem gestörten Autophagosom-Transport. 
Das biphasische Verhalten der Autophagie unter Stress-Bedingungen (frühe 
Induktion, späte Blockade) wurde in verschiedenen Zelllinien unter einem anderen 
Stress- Stimulus (Anisomycin) bestätigt. Hier konnte die Rolle von p38, sowohl in 
Induktion als auch in Blockade der Maturation, nachgewiesen werden. 
 
 
  
 Die Beteiligung des Zytoskeletts in der Blockade der Maturation der Autophagie 
durch p38 wurde ebenfalls im Anisomycin Zellmodel gezeigt. Zusammengefasst, 
konnte diese Arbeit neue Aspekte in der Regulation der Autophagie durch p38 
identifizieren. Die Stärke und Dauer der p38 Aktivierung bestimmt den 
Autophagiefluss, wobei moderate, transiente Stress-Stimuli die Autophagie anregen 
und intensive, anhaltende Stress-Stimuli die Autophagie blockieren. 
 
 
 
 
 
 
 
 
 
 
  
 
                      
 
 
 
 
 
 
 
                     CHAPTER ONE 
                      INTRODUCTION 
 
 
 
  1 
1.0 Introduction 
 
1.1  Autophagy 
Autophagy is the bulk degradation of proteins and organelles, a process essential for 
cellular maintenance and cell viability (Ohsumi, 2001;Reggiori & Klionsky, 2002; 
Thumm,2002; Yoshimori, 2004). It is an evolutionarily conserved mechanism, observed 
in a variety of organisms ranging from yeast and plants to animals, including humans. 
Several genes that are critical for autophagy, called autophagy related genes (Atg), 
have been best characterized in yeast (Klionsky et al., 2003). In mammals, autophagy 
has been observed in many tissues and has been shown to be essential for 
differentiation and development as well as for cellular maintenance. In addition, 
autophagy has been shown to have significant associations with neurodegenerative 
diseases, cardiomyopathies, cancer, programmed cell death, and bacterial and viral 
infections (Baehrecke, 2003; Bursch, 2001; Dorn et al., 2002;  Edinger & Thompson, 
2003 ; Eskelinen et al.,2003; Larsen & Sulzer, 2002; Liebert et al., 2002; Nishino et al., 
2000; Perlmutter, 2002; Tolkovsky et al., 2002). 
 
There are three defined types of autophagy has been discovered: macro-autophagy, 
micro-autophagy and chaperone-mediated autophagy, all of which promote proteolytic 
degradation of cytosolic components at the lysosome. Macro-autophagy delivers 
cytoplasmic cargo to the lysosome through the intermediary of a double membrane-
bound vesicle, referred to as an autophagosome, that fuses with the lysosome to form 
an autolysosome. In micro-autophagy, by contrast, cytosolic components are directly 
taken up by the lysosome itself through invagination of the lysosomal membrane. Both 
macro-and micro-autophagy are able to engulf large structures through both selective 
and non-selective mechanisms. In chaperone mediated autophagy (CMA), targeted 
proteins are translocated across the lysosomal membrane in a complex with chaperone 
proteins (such as Hsc-70) that are recognized by lysosomal-associated membrane 
protein 2A (LAMP-2A), resulting in their unfolding and degradation  (Saftig et al., 2008). 
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1.1.1 Induction and characteristics of autophagy  
Stress stimuli, such as nutrient deprivation often result in the activation of autophagy 
(Klionsky, 1999;  Kim et al., 2000; Emr, 2009). Upon induction of autophagy, a flat 
membrane cistern known as the isolation membrane or phagophore, appears and 
wraps around a portion of cytosol and/or organelles (Klionsky et al.,2007). These 
membranes are formed at either the peri-vacuolar, pre-autophagosomal structure (PAS) 
in yeast or throughout the cytoplasm in higher organisms (Suzuki et al., 2001;Noda et 
al., 2002). Sealing of the edges of the phagophore results in a unique double membrane 
vesicle called the autophagosome that is devoid of any lysosomal enzymes. Once 
formed, autophagosomes undergo a series of maturation processes, during which the 
autophagosomes are delivered to the endosomal lumen, forming unique structures 
called the amphisomes (Berg et al.,1998). The amphisomes eventually form 
autophagolysosomes, upon fusion with lysosomes that are loaded with various acidic 
hydrolases, specialized for rapid and effective degradation of the delivered cargo. The 
pH of the autophagosomes is similar to that of the surrounding cytoplasm, but upon 
 
Figure 1:  Macroautophagy, microautophagy, and chaperone-mediated autophagy 
(adapted from Tanida,2001) 
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fusion with the endosomes and/or lysosomes, the lumenal pH drops due to the 
presence of membrane spanning proton pumps, which in turn results in increased 
lysosomal enzyme (cathepsin) activity (Dunn, 1990). Unlike in mammalian cells, 
however, yeast autophagosomes do not seem to fuse with late endosomes. Instead, 
both autophagosomes and endosomes fuse with the vacuole, the yeast equivalent of 
the lysosome, where their contents are degraded and recycled (Scott & Klionsky, 1998; 
Hanaoka et al., 2002). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2: Overview of macroautophagy. Upon induction of autophagy, a membrane 
of unknown origin forms the initial phagophore or isolation membrane. The phagophore 
expands, forms the double membrane autophagosome. The autophagosome later fuses 
with endosomes and lysosomes to have its internal contents degraded. 
(http://www.mssm.edu/research/labs/yue-laboratory) 
 
 
1.1.2 Molecular mechanism of autophagy 
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1.1.2.1  Phagophore formation 
 
1.1.2.1.1 ULK complex 
 
Autophagosome initiation in yeast is centrally controlled by the Atg1:Atg13:Atg17 
complex. In mammals, the induction of autophagy requires the unc-51-like kinase (ULK; 
ATG1 in yeast), which exists in a large complex with mATG13 and FIP200 that is 
regulated by mammalian target of rapamycin (mTOR) (Ganley et al., 2009). Although it 
bears no structural homology to the yeast counterpart, FIP200 has been proposed to be 
a functional orthologue of yeast ATG17 during autophagosome induction and is 
important for the stability and phosphorylation of ULK1 (Hara & Mizushima, 2009).  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Phosphorylational regulation of ULK1/2 complexes by mTORC1 in 
response to nutrient levels. mTORC1 phosphorylates ULK1/2 and Atg13 and inhibits 
the kinase activity of ULK1/2 under high nutrient conditions. Under starvation, mTORC1 
phosphorylation of ULK complex is suppressed releasing ULK from mTORC1 inhibition, 
which subsequently induces ULK to phosphorylate Atg13, FIP200 and itself (adapted 
from Jung et al., 2009). 
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Under nutrient rich conditions, the ULK complex interacts with mTORC1 and remains 
inactivated by mTORC1-mediated phosphorylation of ULK1 and ULK2. Upon nutrient 
deprivation, mTORC1 dissociates from the complex causing dephosphorylation and 
activation of ULK1 and ULK2, which can then phosphorylate and activate mATG13 and 
FIP200, leading to subsequent localization of the activated ULK complex to the  
phagophore (Jung et al., 2009). Atg101, is a protein conserved in various eukaryotes,  
is important for the stability and basal phosphorylation of Atg13 and ULK1 (Hosokawa et  
al.,2009; al.,2009; Mercer et al., 2009). However, the substrates of the ULK complex 
and how it regulates the autophagic machinery are not entirely known. 
 
1.1.2.1.2 Class III phosphatidylinositol 3 kinase (PI3K) complex 
 
A Class III phosphatidylinositol 3-kinase (PI3K) complex is necessary for the formation 
of phosphatidylinositol 3-phosphate (PI3P), which is essential for the early stages of 
nucleation of the phagophore. The PI3K core complex consists of the PI3K protein 
Vps34, beclin1 (Atg6 in yeast) and its regulatory protein kinase p150 or hVps15 
(Simonsen et al., 2009). Though the exact mechanism is not yet clear, it is evident that 
the core complex localizes to the phagophore and facilitates recruitment of subsequent 
ATGs. Recent studies have identified various binding partners of beclin1, including 
ultraviolet (UV) radiation resistance-associated gene (UVRAG) (C. Liang et al.,2007; 
Itakura et al., 2008), ATG14L/Barkor (Zhong et al., 2009; Matsunaga et al., 2009), 
Ambra1 (Kang et al., 2011) which all positively regulate beclin1 activity and regulate 
different steps of autophagosome formation and maturation. Moreover, another 
molecule named Rubicon (RUN domain and cysteine-rich domain containing, Beclin1-
interacting protein) has been uncovered as a negative regulator of beclin1 (Zhong et al., 
2009), which binds to the UVRAG–beclin complex and regulates late stages of 
autophagy, more specifically, the late endosomal and lysosomal maturation process. 
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1.1.2.2  Phagophore elongation and autophagosome formation 
 
There are two ubiquitin-like systems that are key to autophagy (Mizushima, 2007; Kirkin 
et al., 2009), acting at the Atg5–Atg12 conjugation step and at the LC3 processing step, 
decorate the phagophore surface resulting in the formation of autophagosomes. 
 
1.1.2.2.1  Atg5–Atg12 conjugation 
 
Atg12, a small hydrophilic protein of 186 amino acids, can covalently link to a unique 
target protein, Atg5  (Mizushima et al., 1998). The mode of conjugation of Atg12 and 
Atg5 is quite similar to that of ubiquitination. Atg12 is first activated in an ATP- 
dependent manner by Atg7 (it functions as an ubiquitin-activating enzyme, E1), leading 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4. Two conjugation pathways. Atg5 and Atg12 interact with one another 
through a series of activation and conjugation reactions resulting in the formation of a 
multimeric Atg12-Atg5-Atg16 complex that clusters on the surface of the isolation 
membrane, enabling it to expand and grow into an autophagosome. Similarly, the other 
conjugation pathway involves LC3/Atg8 and plays an equally important role in 
autophagic vesicle formation (adapted from Rosenfeldt 2009). 
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to the formation of a thioester bond between the C-terminal glycine in Atg12 and a  
cysteine residue in Atg7 (Tanida et al., 2001). Atg12 is then transferred to Atg10, an E2-
like ubiquitin carrier protein that potentiates covalent linkage of Atg12 to lysine 130 of  
Atg5 and Atg7 is released. Conjugated Atg5–Atg12 complexes in pairs with Atg16L 
dimers form a multimeric Atg5–Atg12–Atg16L complex that associates with the 
extending phagophore. Once the autophagosome is formed, Atg5– Atg12–Atg16L 
dissociates from the membrane, making conjugated Atg5–Atg12 a relatively poor 
marker of autophagy (Barth et al., 2010).  
 
 
1.1.2.2.2  LC3 processing 
 
The second ubiquitin-like system involved in auto-phagosome formation is the 
processing of microtubule-associated protein light chain 3 (LC3), which is encoded by 
the mammalian homologue of Atg8. LC3 targets to the autophagosomal membranes in 
an Atg5-dependent manner and remains attached even after Atg12-Atg5 dissociates. 
Thus LC3 is the only credible marker of the autophagosome in mammalian cells (Barth 
et al., 2010). LC3 is expressed in most cell types as a full-length cytosolic protein that, 
upon induction of autophagy, is proteolytically cleaved by Atg4, a cysteine protease, to 
generate LC3-I. The carboxyterminal glycine exposed by Atg4-dependent cleavage is 
then activated in an ATP-dependent manner by the E1-like Atg7. Activated LC3-I is then 
transferred to Atg3, a different E2-like carrier protein before phosphatidylethanolamine 
(PE) is conjugated to the carboxyl glycine to generate processed LC3-II. Recruitment 
and integration of LC3-II into the growing phagophore is dependent on Atg5–Atg12 and 
LC3-II is found on both the internal and external surfaces of the autophagosome, where 
it plays a role in both hemifusion of membranes and in selecting cargo for degradation. 
The relative amount of membrane-bound LC3-II reflects the abundance of 
autophagosomes, so the induction and inhibition of autophagy can be monitored 
through measuring total and free LC3-II levels by means of immunoassay (Kabeya et 
al., 2000). 
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Figure 5. Schematic diagram of autophagosome formation in mammalian cells. A 
protein complex, which includes Atg5, Atg12, and Atg16L, is associated with the 
membranes of small cisternae, recruits LC3-II to the membranes, and initiates 
elongation of the membranes. The membranes grow into the isolation membrane and 
eventually mature into autophagosomes. The Apg5 complex leaves the membrane just 
before or after membrane fusion, while LC3 remains (adapted from Yoshimori, 2005) 
 
1.1.2.3 Selective autophagy: cargo for degradation 
 
Several studies have been shown that the growing phagophore membrane can interact 
selectively with protein aggregates and organelles. It is proposed that LC3-II, acting as 
a ‘receptor’ at the phagophore, interacts with ‘adaptor’ molecules on the target (eg 
protein aggregates, mitochondria) to promote their selective uptake and degradation. 
The best-characterized molecule in this regard is p62/SQSTM1, a multi-functional 
adaptor molecule that promotes turnover of polyubiquitinated protein aggregates. 
Mutation of p62/SQSTM1 is linked to Paget's disease, arthritis and nerve injury 
(Ralston, 2008). Other molecules, such as NBR1, function similarly to p62/SQSTM1 in 
promoting turnover of ubiquitinated proteins, while in yeast, Uth1p and Atg32 have been 
identified as proteins that promote selective uptake of mitochondria, a process known 
as mitophagy (Kirkin et al., 2009; Kim et al.,  2007). 
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1.1.2.4 Maturation of autophagosome and its fusion with lysosome 
 
When the autophagosome completes fusion of the expanding ends of the phagophore 
membrane, the next step towards maturation to form the ‘autolysosome’ (Mizushima, 
2007). This aspect of the process is relatively understudied but requires the small G 
protein Rab7 in its GTP-bound state (Gutierrez et al., 2004; Jäger et al., 2004), two 
beclin-1 binding protein Rubicon and UVRAG and also mammalian orthologs of SNARE 
protein family members and the NSF protein for autophagosome maturation. 
 
1.1.2.4.1  The role of the cytoskeleton 
The cytoskeleton plays a role in autophagosome biogenesis and trafficking. 
Autophagosomes utilize microtubule tracks on their way to lysosomes. Among their 
other functions, microtubules serve as roadways for membrane traffic. Destabilization of 
microtubules by either vinblastine or nocodazole blocks the maturation of 
autophagosomes, whereas their stabilization by taxol increases the fusion between 
autophagic vacuoles and lysosomes (Høyvik et al., 1991; Aplin et al., 1992; Yu et al., 
1986). Several studies have confirmed the role of microtubules in the fusion with the 
acidic compartment (Jahreiss, L. et al., 2008; Kochl R. et al., 2006; Webb J.L. 2004). 
Autophagosomes move bidirectionally along microtubules. Their centripetal movement 
is dependent on the dynein motor (Ravikumar, B et al., 2005; Kimura S. et al., 2008). 
Interestingly, the functional loss of dynein has been linked to certain neurodegenerative 
disorders. In vitro studies have demonstrated that the loss of dynein leads to an 
impairment of the clearance of aggregate-prone proteins by autophagy and to increased 
levels of LC3-II, reflecting a defect in the fusion between autophagosomes and 
lysosomes (Ravikumar et al., 2005). This data have recently also been confirmed using 
live-cell imaging analyses that revealed that dynein is required for autophagosome 
trafficking along microtubules and this centripetal movement discontinues once the 
autophagosome reaches the microtubule-organizing centre (Jahreiss et al., 2008). 
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1.1.2.4.2  The role of lysosomal composition in autophagic maturation 
 
Within the lysosome, cathepsin proteases B and D are required for turnover of 
autophagosomes and the maturation of the autolysosome (Koike et al., 2005). Lamp-1 
and Lamp-2 at the lysosome are also critical for functional autophagy, as evidenced by 
the inhibitory effect of targeted deletion of these proteins in mice on autolysosome 
maturation (Tanaka et al., 2000).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6. Autophagosome–lysosome fusion and degradation of intra-
autophagosomal contents.  Autophagosome–lysosome fusion is positively regulated 
by Rab7 and the UVRAG-Vps34-beclin1 PI3-kinase complex, whereas it is negatively 
regulated by the Rubicon-UVRAG-Vps34-beclin1 complex. After the formation of the 
autolysosome, the lysosomal  hydrolases degrade the intra autophagosomal contents, 
including LC3-II. Therefore, the amount of LC3-II decreases during these steps. The 
inset shows the decrease in LC3-II (adapted from Tanida, 2011). 
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Although delivery of the endocytosed cargo to the lysosomes has been widely 
accepted, the mechanisms by which endosomal contents are transferred to lysosomes 
remain controversial. Lysosomes are dynamic, membrane-bound organelles found in 
animal cells containing acid hydrolases   which are kept active with the help of several 
proton pumping vacuolar ATPases, found on the lysosomal and late endosomal 
membranes, which maintain the luminal pH at 4.6-5.0 (Mellman et al. 1986).  
 
Numerous theories exist wherein the endosomes are thought to either  (i) mature into 
lysosomes, the contents are transferred through numerous transient “kiss and run” 
contacts or  (ii) a direct fusion mechanism is employed to form a endo-lysosomal 
compartment, or (iii) hybrid organelle (Luzio et al., 2007). Upon fusion with 
phagosomes, endosomes, or autophagosomes, conventional lysosomes may traffic to 
the plasma membrane to secrete the digested contents out of the cell. 
 
 
1.1.3  Physiological roles of autophagy 
 
Recently, increased numbers of autophagic vacuoles have been found in several 
human diseases including neurodegenerative diseases (e.g., Alzheimer’s, Parkinson’s, 
Huntington’s and Creutzfeldt-Jakob disease), cardiomyopathy (e.g., Danon disease) 
(Ravikumar et al., 2002; Qin et al., 2003; Webb et al., 2003; Shibata et al., 2006). 
 
Upregulation of autophagy is also useful in eliminating pathogens following bacterial 
and viral infections. The pathogens infecting the host cell can be engulfed by the 
autophagosomes and targeted to lysosomes for degradation (Kirkegaard et al., 2004; 
Bélanger et al., 2006;  Tallóczy et al., 2006; Yoshimori, 2006). 
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Figure 7. Physiological signals and diseases related to autophagy. Autophagy is 
induced by many physiological signals and is related to many diseases and processes. 
(adapted from Tanida, 2011). 
 
Another important physiological role of autophagy is in tumorigenesis. Recently, a 
number of studies have shown important but seemingly paradoxical roles for autophagy 
during cancer progression which may depend on tumor type, context and stage. 
Autophagy clearly mediates tumor cell survival and growth during times of nutrient 
starvation or metabolic stress, particularly prior to angiogenesis, and autophagy 
facilitates tumor recurrence following chemotherapy (Lum et al., 2005; Degenhardt et 
al., 2010; Amaravadi et al., 2007; Karantza-Wadsworth et al., 2007). On the other hand, 
however, autophagy also appears to suppress tumorigenesis. This is suggested by the 
fact that tumor cells lose expression of autophagic proteins,  as the level of beclin 1 
expression was shown to be lower in malignant than in normal breast epithelial cell         
(Liang et al., 1999). In addition, gene transfer of beclin 1 was observed to promote 
autophagy in these malignant cells, leading to the loss of malignant morphologic 
features. In addition to beclin 1, other positive regulators of autophagy, such as UVRAG 
also function as tumor suppressors (Xiao et al., 2001;  Liang et al., 2007) and certain 
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negative regulators of autophagy, such as Bcl-2 promote tumorigenesis and prevent 
apoptosis (Kirkin et al.,2004). Moreover, oncogenes like Akt, Ras, and ERK (Furuta et 
al., 2004) inhibit autophagy primarily by activating the mTOR signaling pathway. On the 
other hand, there is abundant evidence that tumor suppressors like p53 (Crighton et al., 
2006), PTEN (Arico et al., 2001) and ARF (Pimkina et al., 2009;  Reef et al., 2006) 
activate autophagy. All together these observations have led to the assumption that in 
non-transformed cells autophagy acts as a tumor suppressor mechanism by preventing 
accumulation of damage and thus avoiding mutations. However, once cells are 
transformed, autophagy promotes tumor cell survival. 
 
The critical role of autophagy in maintaining cell viability upon shortage of external 
nutritional sources was first documented in yeast (Tsukada et al.,1993; Levine et al., 
2004). Later, a similar cytoprotective role of autophagy-dependent production of 
metabolites during nutrient starvation or growth factor deprivation was also 
demonstrated in mammalian cells lacking essential atg genes (Boya et al., 2005; 
Degenhardt et al., 2006; Lum et al., 2005). Autophagy is also involved in removing 
damaged or over-activated and thereby potentially dangerous organelles (mitochondria, 
endoplasmatic reticulum, peroxisomes and lysosomes) as well as cytotoxic protein 
aggregates from the cell thereby promoting cell survival (Bernales et al., 2006; 
Ostenfeld et al., 2008; Iwata et al., 2006). Paradoxically, autophagy has also been 
implicated in cell death called autophagic or type II programmed cell death (Clarke, 
1990; Kroemer et al., 2005).  It is not fully understood the final outcome of autophagy, 
but it does not depend solely on either the cell-type or the stimulus. For example, 
autophagy protects HeLa cervix carcinoma cells against starvation but contributes to the 
death of the same cells following treatment with interferon-Ȗ (Pyo et al., 2005; Boya et 
al., 2005) and tunicamycin-induced autophagy enhances the survival of colon cancer 
cells but contributes to the killing of immortalized murine embryonic fibroblasts (Ding et 
al., 2007). However, the role of autophagy in this type of cell death is currently being 
questioned, as it may reflect cell death with autophagy rather than by autophagy. 
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1.1.4 Regulation of autophagy by signaling pathways  
 
The class III PI3K, Vps34 plays an important role in mediating autophagosome 
formation. It directly interacts with beclin 1 and promotes the formation of the 
autophagosome vesicle (Kihara, A et al., 2001). Class I PI3K can negatively regulate 
autophagy indirectly via Akt and mTORC1. Akt phosphorylates and inhibits TSC2 
(tuberous sclerosis complex-2) which leads to the activationof mTORC1 complex 
resulting inhibition of autophagy (Huang, J et al., 2009). 
Owing to its energy sensing functions, mTOR (the mammalian target of rapamycin) is 
considered the master regulator of autophagy. In yeasts, TOR inhibits the association 
between ATG1 (ULK1 in humans) and ATG13 by hyperphosphorylating ATG13, thereby 
decreasing its affinity for ATG1 (Kamada, Y. et al., 2000; Kamada, Y. et al., 2010). 
Recent studies suggest that when nutrient is abundant, active mTORC1 inhibits 
autophagosome formation by associating with the ULK1-ATG13-FIP200 complex and 
phosphorylating ULK1 and Atg13 (Jung, C.H. et al., 2009; Kim, J. et al., 2011; 
Hosokawa, N. et al., 2009; chan, E.Y. et al., 2009). Inhibition of mTORC1 by rapamycin 
or starvation results in dephosphorylation of ULK1 and initiation of autophagy. mTORC1 
has also been shown to play a role in the termination of autophagy and lysosomal 
homeostasis through an unknown mechanism (Yu, L. et al., 2010).  
The stress-activated AMP-dependent protein kinase (AMPK), which is activated in 
response to stress and low cellular ATP levels is positive regulator of autophagy via 
inhibition of mTORC1 (Gwinn, D.M. et al., 2008; Inoki, K. et al., 2003).  
ERK has been shown to induce autophagy in response to a number of anti-
tumor/cytotoxic agents, such as soyasaponins in colon cancer cells (Ellington, A.A. et 
al., 2006), capsaicin in breast cancer cells (Choi, C.H. et al., 2012) and cadmium in 
mesangial cells (Wang, S.H. et al., 2009; Yang, L.Y. et al., 2009). Inhibition of ERK was 
associated with a decrease in autophagy and increased cellular sensitivity to tumor 
necrosis factor-Į (TNF) in breast cancer MCF-7 cells (Sivaprasad, U et al., 2008). ERK 
was shown to promote TNF-induced autophagy in mouse fibroblast L929 cells by 
activating p53 (Cheng, Y. et al., 2008). Activation of ERK by the transformation of 
human mesenchymal stem cells by H-ras (Shima, Y. et al., 2007), overexpression of 
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TrkA (tropomyosin-related kinase A) in glioblastoma cells (Hansen, K et al., 2007) and 
overexpression of mutant LRRK2 (leucine rich repeat kinase 2) in neuronal cells 
(Plowey, E.D. et al., 2008) was associated with an increase in autophagy. Recent 
studies suggest that ERK regulates the maturation of autophagic vacuoles. Activation of 
ERK has been associated with the formation of large cytoplasmic vacuoles (Martin, P. 
et al., 2006). Lindane-associated formation of large vacuoles, which reflected arrested 
autolysosomes, was shown to be dependent on sustained activation of ERK (Corcelle, 
E. et al., 2006). 
 
 JNK has been implicated in the induction of autophagy by various stimuli, including 
starvation (Li, C. et al., 2006), cytokine stimulation (Jia, G. et al., 2006), T-cell receptor 
activation (Li, C. et al., 2006), neuronal excitotoxic stimuli (Borsello, T. et al., 2003) and 
ER stress (ogata, M. et al., 2006). One mechanism by which JNK contributes to 
autophagy involves phosphorylation of the antiapoptotic protein Bcl-2 (Chen, J.L. et al., 
2008; Nopparat, C., 2010). p38 is another very important signaling pathway in 
autophagy which has been described in next section. 
 
1.2  p38 Mitogen activated protein kinases 
Mitogen-activated protein kinases (MAPKs) are members of discrete signaling cascades 
that serve as focal points in response to a variety of extracellular stimuli and function to 
regulate fundamental cellular processes. In humans, the p38 MAPK family comprises 
four splice variants: p38Į, p38ȕ, p38Ȗ and p38į  (Han et al., 1994; Jiang et al., 1996;  
Jiang et al., 1996;  Jiang et al., 1997a). Of these, p38Į and p38ȕ are ubiquitously 
expressed, whereas the others are expressed differentially in different tissues (Kumar et 
al., 1997). Sequence comparisons revealed that each p38 isoform has more than ~ 60% 
homology, but only 40-45% homology with the other MAPKs, including c-Jun N-terminal 
kinases (JNKs) and extracellular signal-regulated kinases (ERKs). 
 
 
 
 
  16 
1.2.1 Induction and regulation of p38 MAPK activity  
 
p38 is activated by MAPK kinases (MKKs) in response to a wide variety of stimuli, such 
as UV irradiation, heat, osmotic shock, inflammatory cytokines (TNF-Į & IL-1), and 
growth factors (CSF-1, GM-CSF, VEGF , PDGF) (Freshney et al., 1994; Lee et al, 1994; 
Rouse et al.,1994; Raingeaud, 1995.). This plethora of activators conveys the 
complexity of the p38 pathway and this is further complicated by the observation that 
activation of p38Į is not only dependent on stimulus, but on cell type as well. For 
example, insulin can stimulate p38 in 3T3-L1 adipocytes (Sweeney et al.,1999), but 
downregulates p38 activity in chick forebrain neuron cells (Heidenreich etal., 1996) .  
There are two main MAPKKs that are known to activate p38; MKK3 and MKK6 (Jiang et 
al., 1997a). In addition to the activation by upstream kinases,  p38 can also be activated 
through two alternative MKK-independent mechanisms, in a cell type and stimulus-
specific manner. Two mechanisms are known: (i) Phosphorylation of p38 on a novel site 
(Tyr 323) by the ZAP-70 tyrosine kinase (Salvador et al., 2005) and (ii) 
autophosphorylation via a physical interaction with transforming growth factor-ȕ-
activated protein kinase 1 (TAK1)-binding protein (TAB1) (Ge et al. 2002). 
MKK-independent p38 activation has been reported in response to other cytokines and 
nitric oxide (Makeeva, Myers, & Welsh, 2006). In addition, the ZAP-70 mediated 
phosphorylation of p38 has been observed exclusively in T cells (Salvador et al. 2005).  
The activation and subsequent activity of the p38 isoforms are conferred by a Thr-Gly-
Tyr (TGY) dual phosphorylation motif in the regulatory loop between the kinase 
subdomains (Hanks et al.,1995). The glycine residue in the TGY motif and the length of 
the regulatory loop influences p38 substrate specificity and controls 
autophosphorylation (Jiang et al.,1997a; Jiang et al.,1997). Like all MAPKs, p38 
undergoes a sequence of phosphorylation and dephosphorylation events, to act on 
several downstream substrates, including protein kinases or transcription factors, 
resulting in a wide variety of responses. MAP kinase activated protein kinase 2 (MK-2) 
was the first substrate identified to be activated by p38Į  (Rouse et al., 1994). Active  
MK-2 in turn activates other substrates, like the heat shock protein 27 (HSP27), 
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Figure 8. The p38 MAPK pathway. Different stimuli such as growth factors, inflammatory 
cytokines or a wide variety of environmental stresses can activate p38 MAPKs. A number of 
representative downstream targets, including protein kinases, cytosolic substrates, transcription 
factors and chromatin remodellers, are shown (adapted from Cuadrado, A., 2010). 
 
lymphocyte lymphocyte-specific protein (LSP1), cAMP response element binding 
protein (CREB), activating transcription factor 1 (ATF1), serum response factor (SRF) 
and enzyme tyrosine hydroxylase (Stokoe et al.,1992; Tan et al., 1996; Huang et 
al.,1997; Thomas et al.,1997; Heidenreich et al., 1999). MK2 has been found to 
phosphorylate tristetraprolin (TTP), a protein that is known to destabilize mRNA hinting 
at a role for p38 in mRNA stability (Mahtani et al., 2001). MNK1 is another kinase 
substrate of p38 whose function is thought to reside in translational initiation, since 
MNK1 and MNK2 can phosphorylate eukaryotic initiation factor-4e (eIF-4E) 
(Waskiewicz et al., 1997; Fukunaga et al.,1997). Mitogen and stress-activated protein 
kinase-1 (MSK1) can be directly activated by p38 and ERK, and may mediate activation 
of CREB  (Deak et al.,1998), (Pierrat et al., 1998). p38 is also thought to regulate S 
phase activation of histone 2B (H2B) promoter through OCA-S, a component of p38 
(Zheng et al.,2003). In addition to these proteins, p38 MAPK also phosphorylates 
structural proteins, like keratin and stathmin (Parker et al., 1998;  Feng et al., 1999). 
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1.2.2 Biological consequences of p38 MAPK activation 
 
A strong link has been established between the p38 pathway and inflammation. 
Rheumatoid arthritis, Alzheimer’s disease and inflammatory bowel disease are all 
postulated to be regulated in part by the p38 pathway (Johnson, 2003; Hollenbach et 
al., 2004). The activation of the p38 pathway plays essential roles in the production of 
pro inflammatory cytokines (IL-1ȕ, TNF-Į and IL-6) (Guan et al., 1998), induction of 
enzymes such as COX-2 (Badger et al., 1998), expression of intracellular enzymes 
such as iNOS (Da Silva, Pierrat, Mary, & Lesslauer, 1997), induction of VCAM-1 and 
other adherent proteins along with other inflammatory related molecules. In addition, a 
regulatory role for p38 in the proliferation and differentiation of immune system cells 
such as GM-CSF, EPO, CSF and CD-40 has been established  (Kummer, Rao, & 
Heidenreich, 1997). p38 has been implicated in cell differentiation and apoptosis for 
certain cell types. 
There have been reports that activation of p38 led to senescence in response to 
telomere shortening, H2O2 exposure, and chronic RAS oncogene signaling (Wang et al., 
2002;  Haq et al., 2002; Bulavin et al., 2002). A common feature of tumor cells is a loss 
of senescence and p38 may be linked to tumorigenesis in certain cells. It has been 
reported that p38 activation may be reduced in tumors and that loss of components of 
the p38 pathway such as MKK3 and MKK6 resulted in increased proliferation and 
likelihood of tumorigenic conversion regardless of the cell line or the tumor induction 
agent used. p38 has been implicated in G1 and G2/M phases of the cell cycle in several 
reports (Yee et al., 2004; Molnár et al.,1997). G1 arrest of NIH3T3 cells caused by 
microinjection of Cdc42 was found to be p38Į- dependent (Wang et al., 2000). Also a 
link between p38 and G1 cell cycle control has been proposed through the regulation of 
p38 substrates HBP1 and p21 (Yee et al., 2004). p38Į is activated in mammalian cells 
upon M phase arrest by disruption of the spindle with nocodazole (Molnár et al., 1997). 
Furthermore, it has been shown that p38Į and p38Ȗ are required for UV-induced G2 cell 
cycle arrest  (Wang et al., 1998).  
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1.2.3 p38 MAPK and its potential role in autophagy  
 
Activation of p38 was associated with induction of autophagy by polygonatum 
cyrtonema lectin (PCL) in human melanoma cells (Liu et al., 2009), MCP-1 (monocyte 
chemotactic protein-1) in cardiomyoblast (Younce et al., 2010), silibinin in fibrosarcoma 
cells (Duan et al., 2011), bromelain in breast cancer cells (Bhui et al., 2010), oridonin in 
HeLa cells (Cui et al., 2007) and resveratrol in hepatocellular carcinoma cells (Liao et 
al., 2010). The induction of autophagy by p38 was often accompanied by an increase in 
Atg proteins, such as beclin 1 and Atg5 (Kim et al., 2010; Lim et al., 2010). In several 
studies, the tumor suppressor protein p53 was shown to be involved in the autophagy 
induction by p38. Phosphorylation of p53 at Ser392 by p38 enhanced its transcriptional 
activity causing increased expression of beclin1. ER stress-induced beclin 1 expression 
and induction of autophagy also correlated with increased p38 
phosphorylation/activation (Lim et al., 2010).  
 
Contrary to these observations, studies have revealed the induction of autophagy in 
certain types of cancer cells that are depleted of p38 MAPK activity (Comes et al. 2007; 
Simone 2007), suggesting that p38 negatively regulates autophagy. In line with the later 
reports, p38 was also shown to negatively regulate autophagy in other studies.  
Inhibition of p38 in colon cancer cells and myelogenous leukemic K562 cells was 
associated with increase in beclin 1 and induction of autophagy (Thyagarajan et al., 
2010; Colosetti et al., 2009). A recent report demonstrated that p38 inhibits autophagy 
by competing with transmembrane protein mAtg9 for binding to p38 interacting protein 
(p38IP) (Webber et al., 2010).  
 
In summary, the role of p38 in regulation of autophagy has been studied in different 
contexts and cell lines, leading to different observations that appear contradictory or at 
least don´t allow a consensus.  
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1.3 Oncogene-induced Senescence 
 
Senescence was identified by Hayflick and Moorhead, as a process associated with the 
lack of infinite replicative potential of human primary fibroblasts (Hayflick & Moorhead, 
1961). Subsequent work by others demonstrated that the mechanism underlining the 
phenomenon was telomere attrition. This type of senescence was termed ‘replicative’ 
and was suggested to represent a failsafe mechanism preventing the expansion of aged 
cells (Campisi et al., 2007). 
 
Nearly three decades ago, it was observed that normal cells are refractory to oncogene 
transformation (Newbold et al.,1983). In 1997 Serrano and colleagues observed that 
ectopic expression of the oncogene H-RASG12V in normal fibroblast induced 
senescence that was later shown to be telomere-independent (Serrano et al.,1997; Wei 
et al.,1999). Ever since, this form of senescence called ‘oncogene-induced senescence’ 
(OIS) has been displayed by a variety of oncogenes, in vitro and in vivo. 
 
1.3.1 Features of senescent cells 
 
Senescent cells show different features from proliferating cells (Figure-1). Cells remain 
viable, stop to synthesize DNA, i.e. lack 5-bromo-2’-deoxyuridine (BrdU) incorporation, 
do not respond to mitogenic stimuli and their morphological characteristics and function 
change dramatically. The transition from a growing, proliferative state to senescence 
involves gradual but massive changes in cell physiology and protein expression 
(Campisi, 2000; Sitte et al., 2000). Depending on the senescence trigger, cells can 
become large, flat, and multinucleated, or rather refractile. A flat cell phenotype is 
commonly seen in cells undergoing H-RASV12-induced senescence (Serrano et al., 
1997), stress-induced senescence (Parrinello et al., 2003),or DNA damage-induced 
senescence (Chen et al., 2001). Cells senescing due to BRAFE600 expression or the 
silencing of p400, however, acquire a more spindle-shaped morphology. Melanocytes 
undergoing RASV12-induced senescence display extensive vacuolization as a result of 
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endoplasmic reticulum stress caused by the unfolded protein response (Chan et al., 
2005; Michaloglou et al., 2005; Denoyelle et al., 2006).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9. Features of cellular senescence.  Schematic view of a senescent cell 
population with characteristic morphological alterations and typical biochemical markers 
(adapted from Schmitt, 2007). 
 
These changes are accompanied by alterations in nuclear structure, gene expression, 
protein processing, and metabolism. In addition, senescent cells often down-regulate 
genes involved in proliferation and extracellular matrix production, and up-regulate 
inflammatory cytokines and other molecules known to modulate the tissue 
microenvironment or immune response. Consistent with the role of senescence as a 
barrier to malignant transformation, senescent cells activate the p53 and p16/Rb tumor 
suppressor pathways that are required to various degrees in different cell types to 
execute the program (Courtois-Cox et al., 2008). SA-ß-GAL is a commonly used 
senescence biomarker (Dimri et al.,1995; Debacq-Chainiaux et al., 2009). Its increased 
activity in senescent cells derives from lysosomal ß -D-galactosidase, which is encoded 
by the GLB1 gene. 
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1.3.2 Role of senescence on tumorigenesis 
 
Tumorigenesis is a multistep process, in which a normal cell acquires mutations in a 
number of cancer-causing genes. By restricting cell proliferation and thereby impeding 
the accumulation of mutations, senescence acts as an important tumor suppression 
mechanism. Furthermore, senescence induced by aberrant activation of oncogenes, 
oxidative stress, or DNA damage prevents cells at risk of malignant transformation from 
proliferating. Senescence represents a physiologic response that cells must overcome 
in order to divide indefinitely and develop into tumors (Wright et al., 2001; Sharpless et 
al., 2004 ;Campisi, 2005; Sager,1991). 
 
In mouse tumor models with oncogenic Ras, senescent cells are found in premalignant 
lesions in lung (Collado et al., 2005), spleen (Braig et al., 2005), breast (Sarkisian et al., 
2007), and pancreas (Morton et al., 2010).The observation of senescent cells has been 
extended to many premalignant lesions or benign tissues induced by different oncogene 
activation or tumor suppressor inactivation in mouse and human. Importantly, senescent 
cells are absent in malignant tumors, suggesting that oncogene induced senescence is 
a powerful tumor suppression mechanism by restricting proliferation of cells with 
oncogenic mutations and this senescence block must be evaded for malignancy to 
progress. Consistently, deletion of senescence regulators such as p53, Arf, p16, p27, 
SUV39H1 or PRAK abrogates senescence and causes progression of tumors to the 
malignant stage. These observations point to a causal link between loss of senescence 
and malignant transformation (Goel et al., 2009; Young et al., 2008; Bartkova et al.,  
2006; Michaloglou et al.,  2005; Sun et al., 2007). 
 
Besides tumor suppression, senescence can also promote tumorigenesis. Factors 
secreted by senescent cells can promote tumor development in vivo and malignant 
phenotypes such as proliferation and invasiveness in cell culture models. This effect, 
termed the senescence-associated secretory phenotype (SASP), has been observed 
with a number of cell types, including cells derived from breast (Tsai, K.K. et al., 2005), 
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skin (Sun, P. et al., 2007), prostate (Choi, J. et al., 2000), pancreas (Ohuchida, K. et al., 
2004) and oropharyngeal mucosa (Coppe et al., 2008). SASP can also alter the 
microenvironment affecting the neighboring cells. SASP factors can boost up cancer 
progression by stimulating proliferation, inducing epithelial to mesenchymal transition 
(EMT) (Thiery et al., 2009; Parinello et al., 2005; Coppe et al., 2008). 
 
Although paracrine activities of many SASP proteins can promote phenotypes 
associated with malignancy, the SASP is complex and thus not all components are 
cancer promoting. For example, senescent keratinocytes secrete the anti-angiogenic 
factor maspin (Nickoloff et al., 2004). In addition, each SASP factor has effects that 
depend on the cell and tissue context. For example, the IL-6, IL-8, and plasminogen 
activator inhibitor-1 (PAI-1) that are secreted by senescent fibroblasts can promote  
tumor suppression induced by activated oncogenes or oxidative stress (Kortlever et al., 
2006; Acosta et al., 2008; Kuilman et al., 2008). However, IL-6 and IL-8 have also been 
shown to promote malignant tumorigenesis in cooperation with certain activated 
oncogenes (Sparmann and Bar-Sagi, 2004; Ancrile et al., 2007). 
 
1.3.3 The MCF-7/NeuT cell system as a model of oncogene-induced 
senescence 
 
The ERBB2/Neu proto-oncogene is a member of the EGFR family and is overexpressed 
in approximately 15-30% of breast carcinomas (Slamon D.J. et al., 1989). Elevated 
ERBB2 expression is a predictor of poor prognosis with early metastasis and short 
overall survival. Exploiting the tetracycline expression system, it has been previously 
shown that inducible hypermitogenic ERBB2 signaling results in growth arrest of MCF-7 
breast carcinoma cells and activation of the cyclin-dependent kinase inhibitor, P21, is an 
important mediator of this cellular response (Trost et al., 2006; Spangenberg et al., 
2008; Cadenas et al., 2010; Cadenas et al., 2012). This cell system is particularly 
advantageous to be studied as a senescence model because more than 90% cells 
undergo senescence after doxycycline treatment. Furthermore, it resembles other in 
vitro as well as in vivo senescence-associated phenotype (Cadenas et al., 2012).
Aim of the work 
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Aim of the work 
 
Autophagy is an intracellular degradation process that involves sequestering of cellular 
material in autophagosomes and its delivery to the lysosome. Due to the important roles 
of autophagy in cell survival and cell death its levels and flux must be properly regulated 
and adapted to cell requirements.  
 
The aim of this work is to investigate the regulation of the autophagy flux by different 
signaling pathways. The stress activated pathway p38/MAPK is particularly considered 
since its precise role in autophagy is conflicting and thus not clarified up to date. 
Furthermore, the regulation of the autophagic flux will be studied in a time dependent 
manner during the course of exposure to a stress stimulus. For this purpose two models 
of cellular stress are applied: i) a model of oncogene-induced senescence, in which 
preliminary work had provided initial evidence for a deregulated autophagy and ii) a 
model of anisomycin (a protein synthesis inhibitor that activates stress-signaling 
cascades in the cell) induced stress. These investigations require the establishment of 
state of the art techniques to monitor the autophagic flux, such as detection of the 
turnover of the autophagosome marker LC3-II by both immunoblotting and by 
immunofluorescence followed by confocal microscopy. 
 
A further purpose of this study is to identify the molecular mechanism by which the p38 
signaling pathway exerts its regulation on autophagy. This involves identifying targets of 
p38 that are directly or indirectly involved in the autophagic process. 
 
 
  
 
 
 
 
 
 
 
CHAPTER TWO 
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2.1 Materials 
 
2.1.1 Cell Lines 
 
2.1.1.1 MCF7/NeuT  
 
The MCF7/NeuT cell line was generated by Tatjana Trost (Trost et al., 2005) in order to 
study the consequences of overexpressing NeuT, an oncogenic variant of the 
transmembrane tyr kinase receptor ERBB2. This cell model takes advantage of the 
tetracycline-on (Tet-On) system, an expression module that enables tetracyclin-
inducible expression of a gene of interest. For this purpose the human breast cancer 
cell line MCF7 was stably transfected with the pcDNA3Neo/rtTA2 plasmid that allows 
expression of the reverse tetracyclin-dependent transactivator (rtTA) and a second 
plasmid, pINSpBI-EGFP/NeuT, that contains the EGFP reporter and the NeuT gene 
under the control of a tetracyclin responsive element (TRE) as a bidirectional promoter. 
By adding doxycyline, a tetracycline derivative, to the culture medium  the transactivator 
(rtTA) becomes active and binds the TRE whereby expression of both NeuT and the 
EGFP reporter gene become switched on (Trost, et al. 2005). 
 
 
 
 
 
 
 
 
 
 
                              
                              Figure 10: MCF7/NeuT cell transfection constructs 
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2.1.1.2 Human Embryonic Kidney 293 (HEK293)  
 
Permanent human embryonic kidney cell line grown in tissue culture transformed with 
sheared adenovirus 5 DNA and was first described in 1977 (Graham et al.,1977). 
 
 
2.1.1.3 HeLa  
 
HeLa is a widely used human epithelial carcinoma cell line derived from cervical cancer 
cells taken from Henrietta Lacks in 1951. 
 
 
2.1.2 Antibodies 
 
 
2.1.2.1 Primary Antibodies 
 
 
Antibody Host Company Catalog  No. 
Į-Tubulin  Rabbit Cell Signaling    2144 
ß-Actin Mouse Sigma    A5316 
BrdU Rat Serotec MCA2060 
Phospho Akt (Ser473)  Rabbit Cell Signaling    9271 
Total Akt   Rabbit Cell Signaling    9272 
Phospho c-Raf (Ser388)  Rabbit Cell Signaling    9427 
Phospho c-Raf (Ser259)  Rabbit Cell Signaling    9421 
Total c-Raf Rabbit Cell Signaling    9422 
Dynein (DYNLL1) Rabbit Abcam Ab104603 
Phospho p44/42 MAPK 
(Erk1/2) (Thr202/Tyr204)  
 
Rabbit Cell Signaling    9101 
p44/42 MAPK (Erk1/2) Rabbit Cell Signaling    9102 
Phospho SAPK/JNK 
(Thr183/Tyr185)  
Rabbit Cell Signaling    9251 
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Total SAPK/JNK Rabbit Cell Signaling    9251 
LC3 Rabbit Cell Signaling    2775 
Phospho MAP4 (Ser768) Rabbit Ab Frontier LF-PA40702 
Total  MAP4 Rabbit Abcam Ab89650 
Phospho-MEK1/2  
(Ser217/221) 
 
Rabbit Cell Signaling    9121 
Total MEK 1/2 Rabbit Cell Signaling    9122 
Phospho-MSK1 (Ser376) Rabbit Cell Signaling    9591 
Neu Rabbit Santa Cruz  sc-284 
Phospho p38 Rabbit Cell Signaling    9211 
Total p38 Rabbit Cell Signaling    9212 
PARP Rabbit Cell Signaling    9542 
Phospho Stathmin  (Ser16) Rabbit Cell Signaling    3353 
Total Stathmin Rabbit Cell Signaling    3352 
SQSTM1/p62 Rabbit Cell Signaling    5114 
 
   
2.1.2.2 Secondary Antibodies 
 
 
Antibody Company Catalog  No. 
Anti-mouse IgG, HRP linked Cell Signaling     7076 
Anti-rabbit IgG, HRP linked Cell Signaling     7074 
Donkey anti rabbit IgG-cy3 Dianova 712-166-152 
Donkey anti rat IgG-cy3 Dianova 712-166-150 
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2.1.3 Media for cell culture 
 
 Cell  medium FCS Antibiotic 
 MCF7/NeuT DMEM high glucose 10% tetracycline free Penicillin 
Streptomycin 
 HEK293 DMEM high glucose 10% Penicillin 
Streptomycin 
 HeLa DMEM high glucose 10% Penicillin 
Streptomycin 
Gentamycin 
 
2.1.4 Inhibitors 
 
Inhibitor Company Catalog No. 
Anisomycin Sigma, Steinheim     A9789 
Bafilomycin A1 Sigma, Steinheim     B1793 
PD 98059 Sigma, Steinheim     P215 
Phosphatase inhibitor cocktail 2 Sigma, Steinheim     P5726 
Protease Inhibitor Cocktail Sigma, Steinheim     P8340 
SB 203580 Sigma, Steinheim     S8307 
Vinblastine sulfate salt Sigma, Steinheim     V1377 
 
 
2.1.5 Chemical reagents and kits  
 
Reagent/Kit Company 
Acrylamid (30%) C. Roth, Karlsruhe 
Albumin Fraction V (BSA) C. Roth, Karlsruhe 
Ammonium persulfate (APS) Sigma, Steinheim 
Anode Buffer Concentrate A C. Roth, Karlsruhe 
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BCATM Protein Assay Kit Thermo Scientific 
BrdU Sigma, Steinheim 
Bromophenol blue C. Roth, Karlsruhe 
cDNA Kit Applied Biosystems 
Cathode Buffer Concentrate K C. Roth, Karlsruhe 
DAPI Invitrogen , Karlsruhe 
DEPC Treated water Invitrogen , Karlsruhe 
DMEM, high glucose, culture media PAN Biotech GMBH 
Deoxycycline hyclate Sigma, Steinheim 
DMSO C. Roth, Karlsruhe 
DTT C. Roth, Karlsruhe 
Ethanol Th.Geyer, Hamburg 
Entellan Merck, Darmstadt 
FCS, tetracycline free PAN Biotech GMBH 
Formaldehyde C. Roth, Karlsruhe 
Glycerol C. Roth, Karlsruhe 
Glycine C. Roth, Karlsruhe 
Hydrochloric acid C. Roth, Karlsruhe  
Isopropanol C. Roth, Karlsruhe 
Methanol Th.Geyer, Hamburg 
Magic market Invitrogen , Karlsruhe 
Penicillin/Streptomycin PAN Biotech GMBH 
Rapamycin Sigma, Steinheim 
SDS-Pellets C. Roth, Karlsruhe 
Sera Plus fetal calf serum PAN Biotech GmbH 
Sodium hydroxide C. Roth, Karlsruhe 
Sodium chloride C. Roth, Karlsruhe 
Trichlorite acetic acid Sigma, Steinheim 
Tris C. Roth, Karlsruhe 
Triton X-100 C. Roth, Karlsruhe 
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RNAse free water  QIAGEN GmbH 
Sera plus PAN Biotech GmbH 
TaqMan master mix  Applied Biosystems 
Tween®20 Sigma, Steinheim 
Western Lightning® Plus-ECL.  
Enhanced Chemiluminescence Substrate 
Perkin-Elmer 
2-Propanol Roth 
 
 
2.1.6 Buffer and Solution 
 
Anode buffer Buffer concentrate A 
Methanol 
Water 
20 ml 
40 ml 
140 ml 
Cathode buffer Buffer concentrate K 
Methanol 
Water 
20 ml 
40 ml 
140 ml 
Loading buffer (5 x) Bromphenol blue 
DTT 1 M 
Glycerol 
SDS 10 % 
Tris-HCl 1 M 
5 mg 
2.5 ml 
5 ml 
0.5g 
2.25 ml 
Ponseau S Ponseau S  
3 % trichloride acetic acid  
1 g 
500 ml 
RIPA buffer 50 mM tris-Cl (pH 7.5) 50mM 
 NaCl 150 mM 
 NP-40 1% 
 Sodium deoxycholate 0.5% 
 SDS 0.1% 
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Running buffer (10 x) Glycine 
SDS 
Tris base 
144.0 g 
10.0 g 
30.3 g 
Separation buffer 
(3 M Tris-HCl) 
Tris in 100 ml water 
pH set to 8.8 
 
36.34 g 
 
Stacking buffer:  
(0.47 M Tris-HCl) 
Tris in 100 ml water 
pH set to 6.7  
5.69 g 
 
Stripping buffer Glycine                                                                    
SDS                                        
Tween 20                              
pH set to 2.2  
bring up to 1 L with dis. water 
15 g 
1 g 
10 ml 
 
TBS-T 
TBS 
Tween-20 
Water 
H2O replenished to 2.5L 
250 ml 
2.5 ml 
250 ml 
 
5 % BSA solution TBS-T 
BSA 
100 ml 
5 mg 
10% APS Ammonium  persulphate 0.5 g in 5ml 
water 
10 % SDS   SDS  0.5 g in 5 ml 
water 
 
2.1.7 Technical equipment 
 
Equipment  Description, Company 
Autoclave 5075 ELV, Tuttenauer 
Balance EW, Kern 
Benches HERA-Safe, Heraeus 
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Centrifuge  Rotina 35R, Heraeus 
Centrifuge with cooling function Biofuge fresco, Heraeus 
Electrophoresis chamber Biometra 
Hood Heraeus 
Ice machine AF 100, Scotsman 
Incubators Binder 
Magnetic stirrer IKAMAG RCT, IKA 
Microscope Eclipse TS 100, Nikon 
Minishaker MS 2, IKA 
pH meter Schott 
Power Supplies 
Standard Power Pack 25, Biometra 
Power Pack 300, BIO RAD 
Precision balance EW 150-3M, Kern 
Shaker KS 260 basic, IKA 
Spectrometer  Thermoscientific 
TaqMan 7500 Real-Time PCR Applied Biosystems 
Thermocycler TGRADIENT, Biometra 
Thermoshaker 
HTM 130, HLC 
PHMT Grant-bio, Keison 
Transfer chamber  Fastblot B33 / B34, Biometra 
UV/Vis Spectrometer V-530,  Jasco 
Waterbath Labortechnik 
Western blot Chamber Biometra, Bio red 
 
2.1.8 Consumables 
75cm2 Cell Culture Flasks GreinerBio 
24-well Culture Plates Corning 
Cell Scrapers Sarstedt 
PVDF-Membrane Transfer Paper Perkin-Elmer 
Whatman® Paper 3MM Schleicher & Schuell 
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2.2  Methods  
 
2.2.1 Cell Culture 
 
The MCF7/NeuT cell line was routinely cultured in high glucose Dulbecco’s Modified 
Eagle’s Medium (DMEM) containing 1% Penicillin/Streptomycin and 10% tetracycline-
free fetal bovine serum. Cells were incubated at constant humidity in 37°C and 5% CO2. 
MCF7/NeuT cells were seeded onto the suitable culture dishes for each experiment and 
kept in the incubator to attach for a minimum of 24 hours before changing the media 
and adding deoxycycline. Cells were treated with a non-cytotoxic concentration of dox 
(1 ȝg/mL). The media was changed every 48 hours whereby dox was freshly added to 
the cell culture medium. 
 
Cells were passaged before reaching confluency. For this purpose cells were washed 
twice with sterile 1x PBS and trypsin/EDTA mixture was added for detachment of the 
cells from culture flask. The cells were incubated for 5-10 minutes in trypsin/EDATA at 
37 °C and the reaction was stopped by adding normal culturing medium. Next, cells 
were centrifuged for 5 minutes at 600 x g to remove the trypsin. After discarding the 
supernatant, the cells were resuspended in pre-warmed culturing medium and after 
counting the cells a certain volume with the desired cell number was seeded into new 
flasks. 
2.2.2 Gene expression  
The mRNA abundance of particular genes in cells and tissues can be analyzed by 
different types of PCR. For this purpose, the first step is to isolate RNA from the cells 
and to synthesize cDNA. cDNA is more stable than RNA and is suitable as a template 
for PCR ( e.g. Real time-PCR). 
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2.2.2.1 Isolation of RNA 
 
RNA isolation is a technique used to purify RNA 
from biologic samples. In this thesis the 
AnalytikJena innuPREP© RNA Mini Kit was 
applied for RNA isolation and the procedure 
was followed the manufacturer’s protocol. 
Basically, after cell lysation, ribonucleases 
(RNAses) are rapidly denaturated to prevent 
degradation of the RNA. Subsequently, the 
RNA is bound to an affinity chromatographical 
column to separate it from proteins and other 
cell compounds. Finally the RNA is eluted from 
the column at high salt concentrations.  
 
MCF7/NeuT cells were cultured in 6 well culture plates at the specified time points 
needed. In order to extract total RNA, first culture media was removed from the  plate 
and cells were washed twice with 1x PBS. Cells were then trypsinised and resuspended 
in media to stop the trypsinisation. The suspension was then centrifuged at 400 x g for 5 
minutes and supernatant was discarded. 400 ȝL of RL lysis buffer (AnalytikJena) was 
added to the pellet and gently mixed. The tube was then incubated for 2 minutes at 
room temperature and resuspended the cell pellet completely by pipetting up and down. 
To insure complete disruption, cells were briefly vortex before continuing on to the RNA 
isolation steps. Next the supernatant was placed into Spin Filter D in to a 2.0 ml receiver 
tube and centrifuged at 10,000 x rpm for 2 minutes in order to separate protein and 
genomic DNA from RNA. Care should be taken that all of the supernatant passed 
through the filter into the collection tube. An equal volume of 70% ethanol (approx. 400 
µL) was gently mixed into the filtrate by pipetting up and down. The mixed filtrate was 
then transferred to Spin Filter R and centrifuged at 10,000 x rpm for 2 minutes to bind 
the total RNA to the silicon filter. Filtrate was discarded. 500 µL of washing buffer HS 
Figure 11: InnuPREP RNA Mini Kit 
flow chart for total RNA isolation in 
MCF7/NeuT. 
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was added to the spin column of Spin Filter R and centrifuged at 10,000 x rpm for 1 
minutes and filtrate was discarded. Then 700 ȝL of washing buffer LS was added to 
Spin Filter R and centrifuged for 1 minute at 10,000 x rpm and filtrate was discarded. To 
remove any residual ethanol from the filter, the spin filter R was centrifuged for an 
additional 5 minutes at 10,000 x rpm. Spin Filter R was then placed into a micro-
centrifuge tube and 20 ȝL of RNase-free water was added to the spin column. To elute 
the total RNA, the spin column was incubated for 1 minute and centrifuged at 10,000 x 
rpm for 2 minutes. Spin Filter R was then discarded and the total RNA sample was 
stored at - 80°C until needed for further experiments. 
 
 
2.2.2.2 Quantitative RNA Yield 
 
The RNA content in the samples is quantified using the 
Thermo Scientific NanoDrop™ 1000 Spectrophotometer. It 
measures the RNA concentration with high accuracy. The 
principle of a measurement with the NanoDrop is depicted in 
Fig-12. Briefly, 1.5 µl of a sample is pipetted onto the end of 
a fiber optic cable (the receiving fiber). A second fiber optic 
cable (the sampling arm) is then brought into contact with 
the liquid sample. A pulsed xenon flash lamp provides the 
light source. A spectrometer is used to analyze the light after 
passing through the sample. The instrument is controlled by 
PC based software. When the measurement is complete, the 
sampling arm is opened and the sample wiped from both the 
upper and lower pedestals using a soft laboratory wipe.  
The first step is to initialize the machine with 1.5 ȝL of 
RNAse free water. Afterwards, a blank measurement is 
made, also with the 1.5 ȝL of RNAse free water. Then the 
samples can be measured. To quantify the purity of the 
Figure 12: Nanodrop 
measurement (source: NanoDrop 
1000 Spectrophotometer  User’s 
Manual) 
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RNA samples, the program gives three values. The first one is the concentration of RNA 
in ng/ȝl based on absorbance at 260 nm.  The second one is 260/280, the ratio of 
sample absorbance at 260 and 280 nm. This ratio is used to assess the purity of DNA 
and RNA. A ratio of ~1.8 is generally accepted as “pure” for DNA, a ratio of ~2.0 is 
generally accepted as “pure” for RNA. If the ratio is appreciably lower in either case, it 
may indicate the presence of protein, phenol or other contaminants that absorb strongly 
at or near 280 nm. The third given value is 260/230; the ratio of sample absorbance at 
260 and 230 nm. This is a secondary measure of nucleic acid purity. The 260/230 
values for “pure” nucleic acid are often higher than the respective 260/280 values. They 
are commonly in the range of 1.8-2.2. If the ratio is appreciably lower, this may indicate 
the presence of co-purified contaminants. 
 
2.2.2.3 cDNA synthesis 
 
The reverse transcriptase reaction is used to make cDNA out of RNA. mRNA is copied 
to cDNA by the enzyme reverse transcriptase (RT). RT adds complementary nucleotide 
bases to the mRNA strand creating a strand of cDNA, as shown in figure in below. The 
transcription begins at an oligo-dT primer, a short DNA sequence made of dT that binds 
to the poly-A at the 3´end of all mRNAs. Afterwards the enzyme digests and displaces 
the mRNA and synthesizes the second cDNA strand. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13: principle of cDNA synthesis (Source: Hunt, M., Real Time PCR) 
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Here, the cDNA synthesis was implemented with the High Capacity cDNA Reverse 
Transcription Kit from Applied Biosystems. For the reaction 500 ng of RNA are needed. 
From the measured concentration given by the NanoDrop in ng/µl it can be calculated 
how much volume of the cellular RNA extraction must be used. The 500 ng should be in 
10 µl, so water is added if less than 10 µl sample are needed. The needed amount of 
sample and water is given into a reaction tube. Then 10 µl of master mix was prepared 
for per sample containing buffer, free nucleotides as a substrate for DNA synthesis, a 
primer as starting point for synthesis and the reverse transcriptase. All components 
were mixed well and 10 µl of this master mix were then added to every reaction tube 
containing 500ng of RNA to make a final volume of 20 µl. 
 
 The reaction mixture for cDNA synthesis contained the following: 
 
                    Table 1: Composition of the reaction mixture for cDNA synthesis 
 
Compound Volume (µl) 
Master mix   
10x RT-Buffer 2 
25x dNTP 0.8 
Random primer 2 
Reverse transcriptase 1 
H2O 4.2 
Total volume 1 10 µl 
RNA 500 ng 
H2O Up to 10 ul 
Total volume 2 10 µl 
Final total volume 20 µl 
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The thermo cycler was programmed as following: 
 
                           Table 2: Program for the thermo cycler for cDNA synthesis 
 
Step Temperature    Time 
Incubation 25°C    10 min 
Reverse 
transcription 
37°C 
  120 min 
Inactivation 85°C    5 min 
  4°C    hold 
 
Completed cDNA sample was diluted with DEPC water and stored at -20°C for long-
term or at 4°C for short-term.  
 
 
2.2.2.4 Quantitative reverse transcription polymerase chain reaction (qRT-
PCR) 
 
Real Time quantitative Reverse Transcription PCR (qRT-PCR) is a quantitative 
technique which is used to detect and simultaneously quantify the expression level of a 
target gene. This technique is based on the introduction of an oligonucleotide probe, 
called a TaqMan probe, that is constructed containing a high energy dye termed  
Reporter on the 5' end and a low energy molecule termed Quencher  on the 3' end. 
While the probe is intact, the proximity of the quencher dye greatly reduces the 
fluorescence emitted by the reporter dye by fluorescence resonance energy transfer 
(FRET) through space. With the beginning of the extension phase of PCR, the 
polymerase enzyme starts to cleave the TaqMan probe and the distance between the  
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Reporter and the Quencher increases causing the transfer of energy to stop which 
results in a release of reporter dye. An automated sequence detector, equipped with 
specific software, is used to monitor the increasing amount of reporter fluorescent dye. 
During the PCR cycles, Cycle threshold (Ct) values are registered. The Threshold line is 
the level of detection or the point at which a reaction reaches a fluorescent intensity 
above background. The threshold line is set in the exponential phase of the 
amplification for the most accurate reading. 
 
Figure 14:  Real time PCR (Source: www.appliedbiosystems.com) 
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Here in this work, the Real time PCR assays were performed on an ABI 7500 (Applied 
Biosystem) using 96-well plates. The pre-reaction mixture for one sample was pipetted 
according to the following table: 
               
        Table 3: Composition of the TaqMan mastermix for gene expression analysis 
 
Component                               Volume (µl) 
TaqManTM Probe      1 
Universal PCR Master Mix      10 
H2O      6.5 
Final volume      17.5 
 
  
The solution was vortex and 17.5 ȝl of reaction mixture were transferred into each well 
of the TaqManTM plate. Afterwards 2.5 ȝl cDNA of the sample were added and mixed 
with the pre-reaction mixture. The plate was sealed using sealing foils and centrifuged at 
400 x g for 1 minute to remove any bubbles and pull down any liquid. Plates were then 
analyzed in the ABI 7500 Real time PCR System. 
 
The standard amplification conditions are specified in the following table: 
 
               Table 4: Thermal cycling conditions for TaqMan analysis of gene expression 
 
Step Temperature (°C) Time 
 
1. Heating up 50 2 min 
2. Enzyme activation 95 10 min 
3. Denaturation 95 15 sec 
4. Annealing + Elongation 60 1 min 
5. Repetition of steps 3 and  
4, 40 times 
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For quantifying the gene expression levels of a target gene, several quantification 
methods are available: 
- standard curve method 
- relative quantification method 
- comparative threshold method (= ǻǻCt method) 
 
In this thesis, the ǻǻCt method was applied for data analysis. This approach is a 
relative method, exhibiting a correlation between the gene expression stimulated under 
certain conditions and the non stimulated control cells, but not giving absolute values. In 
addition, the expression level of a particular target gene is normalized to the expression 
level of a house keeping gene, which is also measured in parallel. Furthermore, also the 
gene expression of control (= untreated) cells has to be analyzed. 
 
The data is analyzed according to the following calculation steps: 
1. ǻCt1 = Ct target gene – Ct house keeper 
2. ǻCt2 = Ct target gene control samples – Ct house keeper control samples 
3. ǻ Ct = ǻCt1 – ǻCt2 
4. Calculation of 2ǻǻCt 
 
Finally, the 2ǻǻCt is diagrammed in a histogram, showing the fluorescence intensity or 
degree of gene expression for every experimental condition. 
 
2.2.3 Protein analysis  
 
Protein extracts can be effectively obtained from cultured cells and tissues. In order to 
detect a particular protein in a complex sample such as cell and tissue lysates the 
protein samples must be first separated by gel electrophoresis (SDS-PAGE) and 
transferred to a membrane by westernblot. Detection takes place by using an antibody 
that specifically recognizes the target protein. To ensure an equal loading of the 
samples to analyze by SDS-PAGE and immunoblotting, the protein concentration on the 
extracts is determined by the BCA Protein assay. 
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2.2.3.1 Total protein extraction 
 
Here in this thesis, the common cell lysis reagent radio immunoprecipitation assay 
(RIPA) buffer was applied to extract proteins from cell lysates. Cells were grown to 80% 
confluency in culture flask. Prior to extraction, 1 ȝL of Protease Inhibitor (Invitrogen) and 
1 ȝL of Phosphatase Inhibitor (Invitrogen) were added for 1 mL of RIPA buffer and 
mixed gently. RIPA buffer combines ionic and non-ionic detergents like SDS and NP-40 
to break up the cell membrane and release soluble components. Protease and 
phosphatase inhibitor cocktails were added to stabilize the released proteins and 
prevent them from degradation. On ice, RIPA lysis buffer was added directly onto the 
cells and left to incubate for a few minutes. Using a cell scraper, cells were scraped 
from the culture flask and pipetted into micro-centrifuge tubes. Lysate was then left on 
ice for 30 minutes and hardly vortex every 10 minutes for 3 times. Following incubation, 
cell lysates were centrifuged at 13,000 x rpm for 15 minutes at 4°C. The supernatant 
containing total protein was then collected and transferred to a new microcentrifuge 
tube. Total protein lysates were then stored at -80°C. 
 
2.2.3.2 Protein quantification assay 
 
The BCA assay is a bioanalytical technique based on bicinchoninic acid for colorimetric 
detection and quantification of total protein. It is the most popular method and basically 
consists of two reaction steps: 
 
First, the so called Biuret reaction takes place: In an alkaline environment, protein 
amino acid side chains chelate copper and reduce the Cu2+ ions to Cu+. In this step a 
light blue complex is formed. 
 
The second step involved in the assay is the highly sensitive and selective colorimetric 
detection of the resulting cuprous cation (Cu1+) using a unique reagent containing 
bicinchoninic acid (BCA). This occurs by the chelation of two molecules of BCA with one 
cuprous ion, resulting in a purple color product. The BCA/copper complex is water-
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soluble and exhibits a strong linear absorbance at 562 nm. The amount of Cu2+ reduced 
is proportional to the amount of protein existing in the solution. The purple color can be 
measured at any wavelength between 550 nm and 570 nm with minimal (less than 
10%) loss of signal. 
 
 
 
 
Figure 15: Principle of the BCA assay for protein quantification (Lottspeich and Zorbas, 1998) 
 
Protein quantification of all protein samples was determined by using the BCA™ Protein 
Assay Kit (ThermoScientific). The samples were defrosted on ice and then diluted in 
water using 5ȝl of sample and 795 ȝl of water. The working reagent comprises BCA 
Reagent A which contains the bicinchoninic acid and BCA Reagent B, which contains 
4% cupric sulfate. For the working reagent 50 parts of BCA Reagent A were mixed with 
1 part of BCA Reagent B. 200 ȝl of this reagent was added to each sample. In the next 
step the samples were incubated on a shaker at 60°C for 30 min and then incubated at 
room temperature for another 10 min. Afterwards each sample was transferred to a 
cuvette which is placed in a UV/VIS spectrophotometer (V-530, Jasco). The computer 
software “Spectra manager” was used to quantify the samples. Each sample was 
measured three times at 562nm and an average of the concentration was given by the 
program. This value was multiplied with 0.16 to get the concentration in the undiluted 
sample. For a western blot 30 ȝg to 50 ȝg of protein were routinely required. 
 
Materials and Methods 
 44 
2.2.3.3 SDS electrophoresis and western blot  
 
The western blot is a technique for the detection of specific proteins. Thereby SDS poly-
acrylamide gel electrophoresis (SDS PAGE) is used to separate denatured proteins 
according to their molecular weight. Afterwards the proteins are transferred (blotted) to 
a PVDF-membrane for detecting a particular protein of interest.  
 
2.2.3.3.1 Gel preparation 
 
Gels were prepared using the 
Bio-Rad Mini-PROTEAN© 
Tetra Electrophoresis System 
(Bio-Rad), illustrated in Fig.16. 
The gel was prepared with a 
gel cassette assembly. It 
contains a spacer plate, a plate 
with permanently bonded gel 
spacers and a short plate that combines with the spacer plate to form a gel cassette 
sandwich. They were hold together by the casting frame. During gel casting this gel 
cassette assembly was secured by the casting stand.  All glass plates were cleaned 
with 70% ethanol, dried and then placed into the casting frames. Gray seals were 
placed onto the bottom of the casting apparatus to insure no leakage. 
 
The gel contains actually two sequential gels. The top gel is called stacking gel. It is 
slightly acidic (pH 6.8) and has a low acrylamide content to form a porous gel. The 
proteins separate poorly but form sharply defined bands. The lower gel is called 
separating gel. It is more basic (pH 8.8) and has a higher polyacrylamide concentration 
what causes the gel to have narrower pores. As a result, the proteins get concentrated 
into sharp bands by the stacking gel and then travel through the separating gel. There 
the narrower pores have a sieving effect and smaller proteins travel more easily than 
bigger ones. The following table shows the components of the gels.   
Figure 16: Mini-PROTEAN Tetra cell casting    frame 
and casting stand (source: Mini-PROTEAN Tetra Cell 
Instruction Manual from Bio-Rad) 
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                         Table 5: Components of the western blot SDS-gels (10% gel) 
 
 
 
 
 
 
 
 
 
 
 
 
 
Polyacrylamide gels are formed from the polymerization of two compounds, acrylamide 
and N,N-methylenebis-acrylamide (Bis, for short). Bis is a cross-linking agent for the 
gels. The gels are neutral, hydrophilic, three-dimensional networks of long 
hydrocarbons cross linked by methylene groups. The separation of molecules within a 
gel is determined by the relative size of the pores formed within the gel. The pore size of 
a gel is determined by two factors: the total amount of acrylamide present (designated 
as %T) and the amount of cross-linker (%C). As the percentage of acrylamide 
increases, the pore size decreases. TEMED accelerates the polymerization of 
acrylamide and bisacrylamide by catalyzing the formation of free radicals from 
Ammonium persulfate.  
 
For gel preparation all components of the separation gel listed in Table (above) were 
first mixed. Since polymerization is begun as soon as the TEMED has been added, 
without delay the mixture was rapidly swirled and briefly vortexed.  The solution was 
then poured into the gap between the glass plates. The glass plates were not filled 
completely but sufficient space was left for the stacking gel (the length of the teeth of 
 Separation gel    Stacking gel 
 
H2O       3.2 ml 2.4 ml 
Acrylamide       2.64 ml 0.5 ml 
Separation 
buffer 
      2 ml  
Stacking buffer  0.4ml 
10 % SDS       80 ȝl 32.5 ȝl 
TEMED       3.2 ȝl 2.5 ȝl 
10 % APS       80 ȝl 50 ȝl 
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the comb plus 1cm). 1 mL of isopropanol was added to the top of the gel to prevent 
oxygen from diffusing into the gel and inhibiting polymerization. The gel was then left to 
polymerize for approximately 30 minutes at room temperature. After polymerization was 
complete, the isopropanol overlay was poured off and the top of the gel was washed 
several times with deionized water to remove any unpolymerized acrylamide. As much 
fluid as possible from the top of the gel was drained and any remaining water was 
removed with the edge of a paper towel. 
 
 A stacking gel was prepared according the table, mixed quickly following addition of 
TEMED and APS and pipetted directly onto the surface of the separation gel.  A clean 
comb was immediately inserted into the stacking gel solution, being careful to avoid 
trapping air bubbles. More stacking gel solution was added to fill the spaces of the comb 
completely and left the gel for polymerization for 20 minutes. Polymerized gels were 
then stored by removing the glass plates from the casting frame, wrapping in paper 
towels soaked with distilled water and placing them in a plastic bag for storage at 40C 
for up to one week. 
 
 
2.2.3.3.2 SDS gel electrophoresis 
 
Protein samples and marker were first thawed on ice. Based on the concentrations 
calculated from the BCA protein assay, 50 µg of the protein samples were first mixed 
with a required volume of water to unify the concentrations and then diluted using 5X 
loading buffer. Samples were vortexed and then heated at 950C for 5 mins to denature 
the proteins. The addition of the anionic detergent sodium dodecyl sulfate (SDS) in 
loading buffer causes denaturation of the tertiary structure of the protein and all the 
proteins become negatively charged by their attachment to the SDS anions. 
Dithiothreitol (DTT) is usually necessary to reduce disulphide bridges in proteins before 
they adopt the random-coil configuration. Glycerol is added to the loading buffer to 
increase the density of the sample to be loaded and hence maintain the sample at the 
bottom of the well, restricting overflow and uneven gel loading. To enable visualization 
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of the migration of proteins bromophenol blue is used in the loading buffer. The dye will 
migrate the fastest of any component in the mixture to be separated and provide a 
migration front to monitor the separation progress. 
 
The gel was then mounted in the 
electrophoresis apparatus and the comb 
was removed carefully. The wells were 
washed immediately with deionized 
water to remove any unpolymerized  
acrylamide by using a squirt bottle and 
the teeth of the stacking gel were 
straightened properly. 1X Tris-glycine 
running buffer was poured in to the 
inner chamber of the apparatus and 
checked for leaking. Any air bubbles 
that became trapped at the bottom of 
the gel between the glass plates were 
removed. Approximately 20 ȝl of protein 
sample was loaded into its each well 
and an equal volume of 1X loading 
buffer was loaded to empty wells to 
ensure uniform electrophoresis. To 
estimate the molecular weight of the separated proteins, two different protein standard 
markers were additionally loaded on the gel. One gel pocket was loaded with 5 ȝl of 
Precision plus Protein standard to enable a first estimation by eye, in which part of the 
membrane the protein is localized. The second marker was the MagicMarkTM XP 
Western Protein Standard, containing a mixture of proteins with repetitive units of a 
fusion protein forming the size variation and an IgG binding side. This marker only 
becomes visible by applying an enzyme linked antibody and using chemoluminescent 
substrate. 2.5 ȝl of MagicMarkTM XP standards were loaded on the gel. Finally, the 
loaded gel first run at 20 mA until the dye front moved out of the stacking gel. Then the 
Figure 17: Mini-PROTEAN Tetra cell running 
chamber (source: Mini-PROTEAN Tetra Cell 
Instruction Manual from Bio-Rad) 
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gel run at 30mA and run the gel until the bromophenol blue reached the bottom of the 
separation gel. The power supply was then turned off and the gel was removed from the 
electrophoresis apparatus and placed on a paper towel. The two glass plates were 
opened by using a spatula and the orientation was marked by cutting off the top left 
corner of the gel. The gel was then placed in cathod buffer until needed for membrane 
transfer. 
 
 
2.2.3.3.3 Membrane transfer  
 
The proteins are first separated by SDS-PAGE and then, by applying an electric field, 
transferred from the gel on a polyvinylidene difluoride (PVDF) matrix or nitrocellulose 
membrane. In this way, a copy of the protein pattern that was originally in the 
polyacrylamide gel is obtained. After the transfer, the proteins are immobilized on the 
membrane by hydrophobic interactions and hydrogen bonds, but their immunoreactive 
features are preserved. This provides the opportunity to detect and identify single 
proteins by specific antibody reaction out of complex protein mixtures like cell lysates. 
 
Using a semidry dry blot system 
from Biometra, the separated 
proteins were electrophoretically 
transferred to a PVDF membrane. 
16 Whatman papers and a piece 
of PVDF membrane were cut to 
the exact size of the SDS PAGE 
gel and the orientation was 
marked by cutting the top left 
corner off. If the paper or the 
membrane is larger than the gel, 
there is a risk that the overhanging 
edges of the paper and membrane will touch, causing a short circuit that will prevent the 
   Figure 18: Semi dry membrane transfer 
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transfer of protein. Oils and secretions from the skin will also prevent the transfer of the  
proteins from the gel to membrane.  
 
12 pieces of Whatman papers were placed in anode buffer and 4 pieces were placed in 
cathode buffer for several minutes before beginning the transfer to allow the papers to 
equilibrate to the buffer. The membrane was activated in methanol for a few seconds 
and then also left in anode buffer. The Fastblot© B34 (Biometra) electro-blotting 
apparatus was used for transferring protein samples onto the membrane. A ‘paper 
sandwich’ was then prepared as follows from bottom up: 12 Whatman papers, PVDF 
membrane, transfer paper, gel and 4 Whatman papers. To ensure that no bubbles were 
present, a large volume pipette was rolled over the ‘paper sandwich’. The power pack 
was connected and run for approximately 40 minutes at 300 mA per/gel. Current was 
calculated by multiplying 5 mA into the width and length of the gel. After the transfer 
was complete the PVDF-membrane was washed with distilled water for 5 minutes. To 
verify that the proteins were successfully transferred to the membrane, Ponseau S 
prepared in triclorite acid was used. The membrane was stained for 2 minutes with 
Ponseau S and then washed with distilled water to visualize the blot. Later it was 
washed out from the membrane with 1x TBS-T for 5-10 minutes. 
 
 
2.2.3.3.4 Antibody incubation and membrane detection 
 
The membrane was first blocked in 5% non-fat milk or 5% BSA solution in 1x TBS-T, 
depending on the antibody of interest, for 1 hour at room temperature. Primary 
antibodies were prepared in non-fat milk or BSA solution in 1x TBS-T. The final 
concentration depends on the individual antibody.  The membrane was incubated with 
the primary antibody at 4°C overnight in a cold room on a level shaker. Then the 
membrane was washed 6 times for 5 minutes each in 1xTBS-T. The secondary 
antibody was prepared using non-fat milk or BSA solution in 1x TBS-T. The 
concentrations also varied depending on the antibody.   The secondary antibodies used 
for western blot are labeled with horseradish peroxidase (HRP). After incubation of the 
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secondary antibody for 1 hour, the membrane was washed again 6 times for 5 minutes 
each in 1x TBS-T. 
 
 Luminol solution (Perkin Elmer) was prepared in a Petri dish using equal volumes of 
solution A and B (approx. 5 mL total volume). Western Lightning chemistry is based on 
a Chemiluminescence reaction in which the enzyme horseradish peroxidase (HRP) 
catalyzes light emission from the oxidation of Luminol. Because the secondary 
antibodies used for western blot are labeled with HRP the chemiluminiscence is only 
detected in the protein band that has been specically bound by the antibody complex.                                 
 
 
                                 Table 6: parameters for antibodies detection for western blot 
 
Primary 
Antibody 
 
incubation  Dilution Secondary 
Antibody 
Incubation Dilution 
Į-Tubulin  1hr at RT 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
ß-Actin 30 min at 
RT 
1:5000 in 
5% BSA 
Mouse 20 min at 
RT 
1:10,000 in 
5% BSA 
Phospho Akt  overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Total Akt   overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho c-
Raf (S-388) 
overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho c-
Raf (S-259) 
overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Total c-Raf overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Dynein overnight 1:500 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho 
p44/42  
 
overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
p44/42 MAPK  overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho JNK  overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Total  JNK overnight 1:1000 in Rabbit 1hr at RT 1:5000 in 
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5% BSA 5% BSA 
LC3 overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho 
MAP4  
overnight 1:500 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Total  MAP4 overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho-
MEK1/2   
overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Total MEK 1/2 overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho 
MSK1  
overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Neu overnight 1:2000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho p38 overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Total p38 overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
PARP overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Phospho 
Stathmin   
 
overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
Total Stathmin overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
SQSTM1/p62 overnight 1:1000 in 
5% BSA 
Rabbit 1hr at RT 1:5000 in 
5% BSA 
 
Addition of the Western Lightning ECL to the membrane leads to oxidative degradation 
of Luminal resulting in light emission at a wavelength of 428 nm. This light is captured 
with an image acquisition system (Fusion Fx7, Vilber Lourmat). The membrane was 
then placed into the Petri dish and imaged. After imaging of the membrane was 
completed, the membrane was washed in 1x TBS-T for 5 minutes. Membranes could be 
stripped of antibodies by incubation in the stripping buffer for approximately 30 minutes 
followed by a washing step of 5 minutes in 1x TBS-T. To ensure complete removal of 
antibody, the membrane was subjected a second time to the Luminol solution. If the 
antibody was completely stripped from the membrane, it was then washed again in 1x 
TBS-T and stored at 4°C in 1x TBS-T  or air dried and stored at -20°C until needed. 
 
2.2.4 Immunofluorescence 
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Immunofluorescence (IF) is a common laboratory technique allowing the visualization of 
a specific protein or antigen in cells or tissue sections by binding a specific antibody 
chemically conjugated with a fluorescent dye. Fluorochromes are dyes that absorb ultra-
violet rays and emit visible light. This process is called fluorescence. 
Immunofluorescence stained samples are examined under a fluorescence microscope 
or confocal microscope. 
 
The two main methods of immunofluorescent labeling are direct and indirect. In the 
direct method, the cells are incubated with an antibody directly conjugated to a 
fluorochrome. The direct method has the advantage of speed (only one incubation) and 
simplicity but is less sensitive than the indirect method. In the indirect method, cells are 
incubated with a primary non-conjugated antibody, for example, a monoclonal mouse  
 
 
 
 
 
 
 
 
 
 
anti-human antibody. Cells are then stained with a second antibody that recognizes the 
primary antibody, conjugated to a fluorochrome, for example, an FITC-goat anti-mouse 
antibody. This protocol is more complex and time consuming than the direct protocol, 
but it allows more flexibility because a variety of different secondary antibodies and 
detection techniques can be used for a given primary antibody. 
Figure 19: Schematic diagram  of direct and indirect  immunofluorescence.  
                 (source: www.dako.com) 
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2.2.4.1 Immunofluorescence assay for LC3 and Tubulin staining 
 
MCF7-NeuT Cells were seeded onto glass cover slips which were pre-coated by poly-L-
Lysin for overnight inside the 24-well culture plates at a low density. Briefly, cells were 
washed twice with 1x PBS and fixed with 4% paraformaldehyde for 20 minutes at room 
temperature. The purpose of fixation is to denature the components of cells enough so 
that they are preserved without destroying cellular morphology and can be bound by 
antibodies. After fixation, cells were washed twice with 1x PBS for 5 minutes. Cells were 
then incubated with 50 mM Ammonium chloride (NH4Cl) in 1x PBS for 10 minutes to 
quench the aldehyde groups, thereby diminishing autofluorescence and reduce 
background staining and  again washed with 1x PBS for 5 minutes. For blocking, the 
cells were incubated with 3% BSA in 1x PBS for 90 min at room temperature. Cells 
were then washed with 1x PBS for 5 minutes. Incubation with the primary antibody was 
done over night at 40C in a cold room in 0.3% BSA in PBS, 0.1% Tween 20. The 
concentration of antibody depended on the specific antibody of interest. Cells were then 
washed with 1x PBS 3 times for 5 minutes each. The secondary antibody was then 
diluted in a 0.3% BSA, 0.1% Tween 20 solution in 1x PBS and incubated in dark humid 
chamber at room temperature. After secondary incubation cells were washed with 1x 
PBS 3 times for 5 minutes each and a DAPI stain was then performed for 15 min at 
room temperature (1:20000 in 1x PBS) in dark. The fluorescence dye DAPI binds 
selectively to double-stranded DNA and forms blue-fluorescent complexes with A-T rich 
nucleic acid regions. In aqueous solution DAPI has an absorption maximum at a 
wavelength of 340 nm and an emission maximum at 488 nm. It is absorbed by cells 
quickly and the nuclei are stained with a high specificity and cytoplasmic fluorescence is 
not detectable. After the DAPI staining, cells were washed again in 1x PBS 2 times for 5 
minutes. The cover slips were dehydrated using the graded ethanol (30%, 50%, 70%, 
90% and 100% 30 seconds each) and mounted using a drop of entellan on glass slides. 
The slides were dried in the dark for overnight and stored in the cold room until further 
analysis by using a laser scanning confocal microscope (Olympus). 
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                     Table 7: parameters for antibodies detection for immunofluorescence 
 
Primary 
Antibody 
 
incubation  Dilution Secondary 
Antibody 
Incubation Dilution 
Į-Tubulin  overnight 1:200 anti rabbit Cy3 1hr at RT 1:200 
LC3 overnight 1:400 anti rabbit Cy3 1hr at RT 1:200 
BrdU 1hr at RT 1:500 anti rat Cy3 1hr at RT 1:200 
 
 
2.2.4.2 Immunofluorescence Assay for BrdU staining 
 
DNA synthesis of senescence cells were measured by the incorporation of 5-bromo-2-
deoxyuridine (BrdU, catalog B5002, Sigma-Aldrich) into nuclei. Briefly, following pre-
culture for 24 hours in BrdU media (DMEM full medium supplemented with 150µg/ml 
BrdU) the cells were incubated in presence or absence of doxycycline (1ȝg/mL) for 3 
days. The cells were washed with 1XPBS, fixed with 4% paraformaldehyde and 
permeabilized with 0.2%Triton-X100, followed by 10 min incubation with 2N HCl for 
DNA denaturation. Unspecific binding sites were blocked with 3% bovine serum albumin 
(BSA) in 1X PBS for 1h at room temperature, subsequently incubated with rat anti- 
BrdU antibody (catalog MCA2060, Serotec, oxford, UK) for 1 hour at room temperature. 
Detection was achieved by using a secondary donkey anti rat Cy3 antibody diluted in 
0.3% BSA, 0.1% tween 20 in PBS and incubated for 1 hour at room temperature. After 
each antibody incubation, the slides were washed three times with 1X PBS and a DAPI 
stain was then performed for 15 min at room temperature (1:20000 in 1x PBS). After the 
DAPI staining, cells were washed again in 1x PBS 2 times for 5 minutes. The cover 
slips were dehydrated using the graded ethanol (30%, 50%, 70%, 90% and 100% 30 
seconds each) and mounted using a drop of entellan on glass slides. The slides were 
dried in the dark for overnight and stored in the cold room until further analysis. 
Proliferation was expressed as percentage of BrdU positive nuclei, determine by 
counting at least 10 random regions per slide by using fluorescence microscope.
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3.0 Results 
 
3.1 Oncogene ERBB2/HER2 (NeuT) expression leads to premature 
senescence in MCF-7 cells 
 
3.1.1 Expression of oncogenic ERBB2/NeuT in MCF-7 cells 
 
The MCF-7/NeuT cell line harboring a doxycycline (dox) inducible oncogenic version of 
ERBB2 (NeuT) was previously generated by Trost et al. (2005) in order to understand 
the mechanisms involved in oncogene-induced transformation and cellular senescence. 
Further characterization of this cell line was performed by Spangenberg et al. (2006) 
and Cadenas et al. (2010, 2012).  
 
As previously described in the methods section, expression of both the oncogene NeuT 
and the reporter gene EGFP are induced upon exposure of MCF-7/NeuT cells to the 
tetracycline derivate doxycycline. Expression of NeuT results in premature senescence, 
characterized by cell-cycle arrest, expression of the senescence-associated beta-
galactosidase and morphological alterations. As an initial step in this work it was 
necessary to ensure that dox-induced expression of NeuT caused senescence in the 
MCF-7/NeuT cell batches that were used for characterization of the cellular signaling 
network and the autophagy process. 
 
Therefore, in order to confirm the over expression of NeuT in our cell system, protein 
expression of NeuT was monitored by immunoblotting. Already after 6h dox treatment 
NeuT expression was detected and increased further in later time points after addition 
of doxycycline to the culture media (24h-14d). This confirmed previous data (Trost et al., 
2005, Spangenberg et al., 2006, Cadenas et al., 2010, 2012). 
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Figure 20: ERBB2 (NeuT) protein expression in MCF7/NeuT cells. Protein extracts of NeuT 
cells cultured in with or without doxycycline containing media for the indicated time periods were 
immunoblotted and probed for NeuT expression. Į-Tubulin was used as loading control. 
 
 
3.1.2 Oncogene ERBB2/NeuT induced senescence is accompanied by 
alterations in cell morphology in MCF7 cells 
 
Upon up-regulation of NeuT expression, the MCF7/NeuT cells begin to display first 
shape-related alterations, such as cytoplasmic protrusions. Following this stage, 
prolonged dox treatment (3 days) resulted in senescence-like characteristics such as an 
enlarged and flattened-type morphology, a centralised nucleolus and the development 
of vacuole structures within the cytoplasm. These morphological alterations were only 
observed in EGFP-positive cells. As previously mentioned, EGFP is co-expressed with 
NeuT and thus serves as an indirect measure for NeuT expression. 
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Figure 21: Morphological changes during NeuT oncogene induction. MCF-7/NeuT cells 
were treated with or without dox at different time points. Cells treated with dox for 3 days 
displayed an enlarged cytoplasm, increased levels of vacuoles and a centralised nucleolus 
(upper panels). MCF7/NeuT cells showing these alterations upon dox exposure also expressed  
the green fluorescent protein, EGFP (bottom pannels). Images are reprsentative for multiple 
images taken of each condition. Bar, 100 µm. 
 
 
3.1.3 ERBB2/NeuT over expression induces growth arrest in MCF-7 cells 
 
To further study the effect of oncogenic ERBB2 signaling on proliferation of MCF7 cells, 
we used the bromodeoxyuridine-incorporation (BrdU) assay. This synthetic analogue is 
incorporated into DNA instead of thymidine during S phase.  
 
For the BrdU assay, MCF-7/NeuT cells undergoing senescence by addition of dox were 
incubated with BrdU for 24h. After treatment, the nuclei were stained with an anti-BrdU 
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antibody to detect incorporated BrdU, in addition to the conventional DAPI staining. In 
doing so, nuclei that were BrdU positive or negative, i. e. cells that have already 
undergone DNA replication or have not yet incorporated BrdU, can be easily 
distinguished because of their different fluorescent colours. 
 
Figure 22: Decreased BrdU-staining in 3 days dox-treated MCF-7/NeuT cells confirms cell 
cycle arrest upon senescence. A. BrdU-positive (pink) and BrdU-negative (blue) nuclei 
appear in different fluorescent colours. A representative picture is shown. B. Differences in 
proliferation rate were quantified by calculating the ratio of BrdU-positive cells and total number 
of cells in 10 random fields per slide.  
3d doxControl
A
B
0
10
20
30
40
50
60
70
80
3days
Time
P
ro
lif
er
at
io
n 
Ra
te
 in
 %
Control
Dox
 
Results 
 59 
Quantification of BrdU incorporation was performed by counting all nuclei and the BrdU-
positive nuclei, respectively, in randomly chosen fields of the slides using a fluorescent 
microscope. The proliferation rate was defined as the ratio of BrdU-positive nuclei and 
total number of nuclei per field denoted in percentage. Our result indicated the 
decreased cell proliferation upon NeuT induction. This cell cycle arrest was a specific 
response to oncogene ERBB2/NeuT signaling because no influence on proliferation 
was seen in the control cells. Therefore, we could confirm the proliferation arrest in 
MCF-7/NeuT senescent cells. 
 
 
3.2 ERBB2/NeuT oncogene-induced activation of signaling pathways in 
senescent cells 
 
NeuT overexpression results in activation of various signaling pathways, including the 
Ras/Raf/MEK/ERK and the PI3K/AKT pathways (Dissertation Tatjana Trost; Cadenas et 
al., 2010). p38 becomes also activated at a later time points, whereby it is involved in 
mediating the senescence transition (Trost et al., 2005). Since the aim of our work was 
to explore regulation of various cellular events, including senescence and autophagy, by 
signal transduction pathways, we studied first the time-course activity of three major 
pathways, the Ras/Raf/MEK/ERK, the AKT/PI3K and the p38 pathway, in the MCF-
7/NeuT cells during a 14 days period following doxycycline exposure. 
 
 
3.2.1 Activation of the Raf/MEK/ERK cascade by the ERBB2/NeuT 
oncogene 
 
The Ras protein activates multiple downstream pathways, including the Raf-MEK-ERK 
pathway and induces pleiotropic phenotypes. In many studies overexpression of Ras or 
Raf protein has been described to elicit growth arrest and premature senescence in 
several cellular settings (Cox et al., 2006, Zhu et al.,1998). To investigate the activity of 
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the Raf-MEK-ERK pathway during ERBB2 (NeuT) induced senescence, we monitored 
the phosphorylation of each of the pathway components by immunoblotting. 
 
We first studied the expression level and activity of the Raf-1/c-Raf protein. The Raf-1/c-
Raf (serine/threonine-specific protein kinase) is the first component of this three-tiered 
protein kinase cascade. Phosphorylation plays a key role in c-Raf activation and both 
positive and negative regulatory sites have been mapped. Among them, S338 
phosphorylation is the key activating site for c-Raf activation (Avruch et al., 2001; Kolch, 
2000). Therefore, first we examined phosphorylation of c-Raf protein at different time 
intervals of dox treatment, using a phospho-specific antibody against S338. Low levels 
of basal S338 phosphorylation were observed in control cells, but within 6 hours of dox 
treatment, phosphorylation was elevated and continued to rise over 3 days time period. 
After reaching the maximum phosphorylaton, activation of c-Raf decreased and 
returned to basal levels after 10 days dox treatment. 
 
 
 
Figure 23: Activation of Raf-1/ c-Raf upon NeuT expression. A representative immunoblot is 
shown for activation of c-Raf during NeuT-induced senescence. Samples from left to right; non-
treated control, treatment of dox in different time intervals. Į-Tubulin was used as the loading 
control. 
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We next investigated another c-Raf phophorylation site, S259 (Dhillon et al., 2002). 
Importantly, the dephosphorylation of S259 is a prerequisite for the activation of c-Raf 
and S259 dephosphorylated before activating phosphorylation on S338 can occur. In 
control cells, c-Raf is phosphorylated at the S259 site but already 6h after NeuT 
induction S259 becomes dephosphorylated concomittant with S338 phosphorylation. In 
the late senescent stage (10 days after NeuT induction/dox treatment) S259 
phosphorylation is restored to initial levels, concomittantly with S338 dephosphorylation. 
 
MEK is the second tier of this cascade and phosphorylation of two serine residues 
(residues at positions 217 and 221 found in the activation loop) are thought to be 
important for its synergistic activation by Raf-1/c-Raf (Alessi et al,. 1994). MEKs can be 
partially activated by phosphorylation at either site and substitution of these sites with 
acidic amino acids enhances basal activity (Mansour et al.1994). To monitor activation 
of MEK1/2 in senescent cells, cell lysates of different dox treatment time periods were 
subsequently analyzed for phosphorylation events. Dox treatment induced early MEK12 
activation, which peaked to a maximum after 3 days and gradually declined to nearly 
basal levels during further dox incubation. 
 
 
Figure 24: Phosphorylation of MEK1/2 in MCF-7/NeuT cells. Lysates obtained from different 
time points of dox treatment were subjected to immunoblot analysis using anti-MEK and anti-
phosphorylated MEK antibodies. Į-Tubulin was used as the loading control. 
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ERK1 and ERK2 are 44 and 42 kDa serine/threonine kinases, respectively and dual 
threonine and tyrosine residue phosphorylations activate both ERKs, at Thr202/Tyr204 
for human ERK1 and Thr185/Tyr187 for human ERK2. Unlike MEK, significant ERK 
activation requires phosphorylation at both sites, with tyrosine residue phosphorylation 
preceding that of threonine (Ferrell, J.and R. Bhatt, 1997). Because ERK is the only 
downstream-substrate of MEK, it was expected that dox stimulation would quickly 
induces ERK activation with similar kinetics to that of MEK phosphorylation. As 
expected, we could show that phosphorylation of ERK appeared 6h after NeuT 
induction, peaked after 3 days dox-treatment and returned to nearly basal levels after 
10 days of incubation. 
 
 
Figure 25: Activation of ERK1/2 during NeuT oncogene-induced senescence. Cells were 
subjected to immunoblot analysis for studying activation of ERK1/2 in presence or abcence of 
dox at different time periods. Į-Tubulin was used as the loading control. 
 
 
3.2.2  Activation of the PI3K/AKT pathway during NeuT induced senescence  
 
It has been shown that AKT becomes activated during oncogene-induced senescence 
but its specific contribution remains controversial. Previous studies do not present a 
clear picture regarding the ability of activated AKT to induce senescence. Some reports 
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have indicated that activation of the AKT pathway does induce senescence (Chen et al., 
2005; Majumder et al., 2008; Miyauchi et al., 2004; Nogueira et al., 2008; Oyama et al., 
2007). Other reports have concluded that AKT activity is a weak inducer of senescence 
(Lin et al., 1998) or is down regulated in senescence (Courtois-Cox et al., 2006; Young 
et al., 2009) and can antagonize senescence (Courtois-Cox et al., 2006; Kortlever et al., 
2006; Tresini et al., 1998). In order to investigate the activity of the PI3K/AKT signaling 
pathway in our NeuT cell system, the phosphorylation status of AKT was determined by 
western blot analysis using corresponding phospho-specific antibodies, which are 
designed to recognize only the activated form of AKT.  Our result showed that soon 
after the onset of Dox exposure AKT phosphorylation increased which peaked at 24hrs 
and returned to basal levels at the later senescence phase. 
 
 
Figure 26: Activation of the AKT pathway in MCF-7/NeuT cells. AKT phosphorylation was 
induced early after onset of NeuT expression and decreased in late senescence. Samples from 
left to right: non-treated control, treatment of dox in different time intervals. Į-Tubulin was used 
as the loading control. 
 
A key regulator of protein metabolism, the mammalian target of rapamycin (mTOR), is a 
serine/threonine protein kinase. mTOR forms two distinct signaling complexes: mTOR 
complex 1 (mTORC1) and mTORC2. mTOR is a downstream effectors of the AKT/PI3K 
pathway. To examine the activity of mTOR during senescence, we assessed the 
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phosphorylation status of mTOR. The level of p-mTOR, showed a similar pattern to p-
AKT, initially up-regulated in response to the mitotic signal, while it decreased during the 
senescence phase. 
 
Figure 27: Phosphorylation of mTOR in MCF-7/NeuT cells. Cells were subjected to 
immunoblot analysis for analysing activation of mTOR in presence or absence of dox at different 
time periods. Į-Tubulin was used as the loading control. 
 
 
3.2.3 p38 is activated during NeuT induced premature senescence 
 
Several studies, including those previously performed with our MCF-7/NeuT cell line 
(Trost et al., 2005) have shown that the stress-activated protein kinase p38 mediates 
senescence. To confirm activation of the p38 pathway and to further explore its role in 
oncogenic ERBB2-induced senescence, we examined MCF7/NeuT cells undergoing 
premature senescence at different time points of doxycycline treatment. The 
phosphorylation of the p38 on Thr180 and Tyr182 is known to lead to the activation of 
the p38 signaling pathway (Deng et al., 2004). Consistent with prior reports (Trost et al., 
2005), phosphorylation of p38 on Thr180 and Tyr182 was observed in western blot 
analysis using an antibody that specifically recognizes p38 phosphorylation on these 
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sites. Phosphorylated p38 was clearly observed 3 days after NeuT induction and was 
sustained throughout senescence (up to 14 days). 
 
 
 
Figure 28: Activation of the p38 signaling pathway upon NeuT expression. A 
representative immunoblot is shown for activation of p38 in senescence cells. Į-Tubulin was 
used as the loading control. 
 
 
3.2.4  JNK signaling pathway is not activated during senescence 
 
The c-Jun N-terminal kinase (JNK) is a stress-activated member of MAP kinase family. 
Therefore, we investigated the role of JNK activation in our senescence cell model. Our 
result showed that the phosphorylation of JNK levels was unaltered relative to control 
cells after time dependent dox treatment. This data suggested that activation of JNK 
has no effect on premature senescence induced by oncogene ERBB2/NeuT. 
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Figure 29: Phosphorylation of JNK pathway in MCF-7/NeuT cells. Lysates obtained from 
different time points of dox treatment were subjected to immunoblot analysis using anti-JNK and 
anti-phosphorylated JNK antibodies. Į-Tubulin was used as the loading control. 
 
 
3.3 Autophagy in oncogene-induced senescence cells 
 
Autophagy is an evolutionarily conserved eukaryotic degradation pathway involved in 
the turnover and elimination/recycling of cellular proteins and organelles. 
 
Several studies have shown that the above described signaling pathways have an 
influence on the autophagy flux in different ways. While activation of the MEK1/2-
ERK1/2 signaling pathway leads to induction of autophagy, activation of the AKT/mTOR 
pathway has been shown to inhibit it. On the other hand, activation of the p38 signaling 
cascade is reported to affect autophagy in various ways that appear somehow 
contradictory. In our cell model, we found that both ERK1/2 and AKT are rapidly 
phosphorylated upon NeuT induction and become dephophorylated in the late 
senescence phase. In contrast, the p38 pathway becomes activated with the onset of 
Results 
 67 
senescence and remains phosphorylated throughout senescence. (Fig-25, Fig-26 and 
Fig-27).  
 
One of the most prominent morphological alterations observed in the MCF-7/NeuT 
senescencent cells is a strong cytoplasmic accumulation of vacuolar structures. These 
vacuoles have been shown to be acidic by Lysotracker staining (Cadenas et al., 2012), 
suggesting that they may be components of the lysosomal degradative system. Strong 
accumulation of autophagic vacuoles may reflect a deregulated autophagy flux. This 
observation, together with the activity pattern of signalling pathways involved in 
regulating autophagy  prompted us to explore the regulation and role of autophagy in 
oncogene induced senescence. 
 
MAP1LC3 (LC3) is a widely used marker of autophagy. Post translational modification 
of cytosolic LC3-I to LC3-II is followed by LC3-II translocation to nascent 
autophagosomal membranes, which is a useful index of autophagosome formation 
(Mizushima, 2010). The lipid conjugated form of LC3 (LC3-II) can be separated from the 
nonconjugated form (LC3-I) by SDS-PAGE and LC3-II levels reflect the abundancy of 
autophagosomes. Therefore, the first approach was to study levels of LC3-II during 
NeuT-induced senescence.  
 
In our MCF-7/NeuT cell system, LC3-II levels were elevated after 24 hr dox treatment 
and increased further in the senescence phase, reflecting higher numbers of 
autophagosomes. In addition to LC3 II, we also monitored the levels of an 
autophagosomal cargo adaptor, p62/SQSTM1. p62 directly binds to LC3  and becomes 
itself degraded during the autophagic process (Pankiv et al., 2007; Ichimura et al., 
2008). According to the literature, increased amounts of p62 may indicate a blockade of 
autophagy. Our results showed accumulation of p62 after onset of senescence, which 
might represent the impairment of autophagy in our senescence cell model. 
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Figure 30: Increased levels of autophagosomes in senescent cells. Western blot analyses 
showing increased amounts of the autophagosome marker LC3-II and the cargo-adaptor protein 
p62 in senescent cells. Į-Tubulin was used as the loading control. 
 
 
In order to provide evidence that the increased vacuolization and LC3-II levels are 
related to autophagy, we treated our cells with 3-methyladenine (3-MA) at different dox-
treatement time intervals. 3-MA is one of the most widely used inhibitor of autophagy 
that suppresses the autophagic/lysosomal pathway by inhibiting class III PI3Ks (Lin et 
al., 2012). We found that in senescent cells the cytoplasmic vesicles were diminished by 
incubating with 3-MA (Fig-31A). We also analyzed the expression of the 
autophagosome marker LC3-II by immunoblot. LC3-levels became reduced to the basal 
level in presence of 3-MA (Fig-31B). This result indicated that the vacuolization 
observed in senescent cells was due to accumulation of autophagic vesicles. 
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Figure 31: Inhibition of autophagy by 3-MA treatment. A. Morphological changes of 
senescent cells by incubation with 5 mM of 3-MA. B. Expression of the autophagic marker LC3-
II after treatment with 5 mM 3-MA at different times of dox exposure. 
 
3.4 Autophagy maturation is impaired in senescent cells 
 
Since LC3-II is itself degraded during the autophagy process due to its localization in 
autophagosomes, LC3-II accumulation may reflect either autophagic induction by 
enhanced formation of autophagosomes or blockade of autophagosome degradation. In 
order to discriminate between these two possibilities we performed the LC3-II turnover 
assay according to the proposed guidelines (Klionsky, 2008).   
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Figure 32: LC3-II turnover assay reveals a biphasic behavior of autophagy. Cells were 
incubated overnight with rapamycin (100nM) as a positive control for autophagy induction. In the 
turnover assay, cells were treated with 50 µM of vinblastine for 2 hours before lysate extraction. 
Induction of autophagy is shown at 24h+dox, whereas the block of autophagosome (LC3-II) 
degradation is shown after 3d-14d+dox. ȕ-Actin was used as the loading control. 
 
In this assay the autophagy flux is monitored by experimentally blocking lysosomal 
degradation. Accumulation of the autophagosome marker LC3-II or of any cargo protein 
during this block is an indicator of a previously active autophagy flux. To monitor the 
autophagic flux in our MCF-7/NeuT cells we incubated cell cultures for 2 hours with 
vinblastine before harvesting. Vinblastine is a microtubule destabilizer which is known to 
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impair fusion of autophagosomes with lysosomes. In pre-senescent MCF-7/NeuT cells 
(6h-24h+dox), vinblastine induced a dramatic increase of LC3 II suggesting that the 
autophagy flux is induced at this stage. The levels of p62 expression also accumulated 
by vinblastine treatment. In contrast, after exposure to vinblastine in the senescent 
stage (3d-14d+dox), neither the autophagic marker LC3-II nor the cargo protein p62 
showed further accumulation, showing that senescent MCF-7/NeuT cells have already 
an impaired flux . 
 
To further confirm this result we also assessed the LC3-II turnover assay in the 
presence of bafilomycin A1, a specific inhibitor of the vacuolar type H(+)-ATPase, which 
inhibits lysosome acidification. As expected, similar results were obtained when levels 
of LC3-II and p62 were monitored, which confirmed the two phases in the autophagy 
flux upon oncogene overexpression: I) enhanced flux in the pre-senecent stage (high 
LC3, low p62) and ii) blocked flux in the senescence stage (high LC3, high p62).  
Figure 33: Impairment of autophagy maturation in senescence. Cells were treated with 200 
nM of  bafilomycin for 2 hours before cell lysate extraction. Induction of autophagy is shown at 
24h+dox, whereas block of autophagosome (LC3-II) degradation is shown after 3d-14d+dox. ȕ-
Actin was used as the loading control and  rapamycin (100nM) as a positive control for 
autophagy induction. 
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In conclusion, our data shows that NeuT expression leads initially to induction of 
autophagy. However, after the onset of senescence, accumulation of autophagosomes 
is due to a blockade in autophagosome turnover. 
 
3.5 Senescence-associated blockade of the autophagic flux is triggered by 
the p38-MAPK pathway 
 
In order to investigate the mechanisms that lead to the initial induction of autophagy and 
the later block of its flux in senescence, we applied small molecule inhibitors of the 
pathways previously shown to be induced upon NeuT expression. Since 
phosphorylation of p38 matched to the appearance of the autophagy flux blockade, we 
investigated whether the p38 pathway would be responsible for the impaired autophagy 
flux by applying a pharmacological inhibitor of p38, SB203580. After treating MCF-
7/NeuT cells with the SB203580 inhibitor, we found absence of autophagic vacuoles in 
senescence. This indicated the participation of the p38 pathway in accumulation of 
autophagosomes (Fig- 34A). 
 
To further study the role of p38 in autophagy during senescence, we performed the 
turnover assay. Inhibition of p38 by the SB203580 inhibitor has no effect on LC3-II 
levels in untreated MCF-7/NeuT cells or in MCF7/NeuT cells in the pre-senescent stage 
(6h-24h+dox). This can be explained by the fact that p38 is not maximally activated at 
this stage, as shown by lack of phosphorylation of the p38-substrate MSK1. In addition, 
this shows that induction of autophagy in the pre-senescence phase is p38-
independent. In contrast, incubation of MCF7/NeuT senescent cells (3d-7d+dox) with 
the SB203580 inhibitor completely blocked accumulation of LC3-II (Fig-34B). The 
efficiency of p38-inhibition by SB203580 was confirmed by monitoring phosphorylation 
of MSK1. Addition of vinblastine to SB-treated cells resulted in a new accumulation of 
LC3-II. 
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Figure 34: Impaired autophagic flux is mediated by the p38 signaling pathway in 
senescence. MCF-7/ NeuT cells were pre-incubated with SB203580 (20µM) for 1hr before time 
dependent dox treatment. Before protein lysate extraction cells were exposed for 2 hours to 
vinblastine (50µM). ȕ-Actin was used as the loading control. 
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This showed that p38 blocks the completion/maturation of the autophagy process and 
SB203580 restored a basal-like autophagic flux that can be impaired by additional 
treatment with autophagy flux inhibitors. We also studied the impact of SB203580 
mediated inhibition of p38 on p62/SQSTM1 abundance: (As shown in Fig-34B), i) p62 
only accumulates in senescent (and not in pre-senescent) cells as a result of impaired 
autophagy, ii) its accumulation in senescence is not further enhanced by vinblastine 
treatment, showing that the flux is already blocked and iii) SB-treatment impairs 
accumulation of p62 in senescent MCF-7/NeuT cells (3D-7D+Dox), which can 
accumulate by additional vinblastine treatment.  
 
Identical results were obtained when bafilomycin A1 was used instead of vinblastine to 
confirm the blockade of autophagy by p38 pathway in senescence cells . 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 35: p38 signaling pathway mediates blockade of autophagy in oncogene-induced 
senescence. MCF-7/ NeuT cells were pre-incubated with SB203580 (20µM) for 1 hr before time 
dependent dox treatment. Before protein lysate extraction, cells were exposed for 2 hours to bafilomycin 
(200nM). ȕ-Actin was used as the loading control. 
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Monitoring LC3 puncta formation by immunofluorescence of endogenous LC3 
(Mishuzima et al., 2007, Klyonki et al., 2008, Mishuzima et al., 2010) in presence or 
absence of SB and/or autophagy flux inhibitors further confirmed our results and  
 
Figure 36: Detection of LC3-puncta by confocal microscopy. Cells were subjected to dox-treatment at 
the indicated time points. Pre-incubation with SB203580 (20µM) was done for 1 hr before  dox treatment. 
Before fixation, cells were exposed for 2 hours to vinblastine and detection of LC3 was performed by 
immuno staining. The nuclei were labelled with DAPI; blue (DAPI), red (LC3) and green (EGFP). Images 
are representative of multiple images taken of each condition. Bar; 50 µm. 
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showed that LC3-puncta (and thus autophagosomes) that accumulate in senescence 
(3d+dox) cannot be increased by treatment with vinblastine. As described above,  
SB203580 treatment lead to reduced levels of LC3-puncta, which further increased by 
treatment with vinblastine. Blockage of the autophagy flux by the p38 pathway and 
release of this blockage by adding SB203580 inhibitor was therefore confirmed as well 
by immunofluorescence of LC3 puncta. 
 
3.6 The MEK1/2-ERK1/2 signaling pathway is involved in initial induction of 
autophagy upon NeuT induction 
 
Activation of extracellular signal-regulated kinases (ERK1/2) has been shown to induce 
autophagy in different cell types such as in neurons (Zhu et al., 2003) and in human 
colon cancer cells (Pattingre et al., 2003). Therefore, we also investigated the role of 
ERK signaling pathway in our oncogene-induced cell system. To do so, we treated our 
MCF-7/NeuTcells with the MEK inhibitor PD98059. Our first results showed that PD did  
not alter senescence cell morphology, since senescence-associated flattening and 
vacuolization were still observed after PD98059 treatment (Fig-37A). 
 
To explore the regulation of autophagy by the MEK-ERK1/2 signaling pathway, we 
performed the turnover assay in combination with the PD98059 inhibitor.  
 
Our results showed that in the pre-senescent stage (6h-24h+dox), the MEK/ERK1/2 
pathway is responsible for the enhanced autophagy flux since addition of PD98059 
inhibits the accumulation of LC3-II-positive autophagosomes observed at this stage. In 
contrast, incubation of MCF7/NeuT senescent cells (3d-7D+dox) with PD showed no 
effect on LC3-II and cargo protein p62 levels. Although activity of the ERK signaling 
pathway is still high at this stage (phospho-ERK1/2 is observed in dox-treated cells), it 
has no influence on the autophagy flux in senescent cells (Fig-37B).  
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Figure 37: Inhibition of the ERK signaling pathway influences early (24h) LC3-II levels but 
has no effect on autophagy maturation in late senescence (3-7 days). MCF-7/NeuT cells 
were pre-incubated with PD98059 (50 µM) for 1h before time-dependent dox-treatment. Before 
protein lysate extraction cells were exposed to vinblastine (50 µM) for 2h. ȕ-Actin was used as 
the loading control. 
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This result suggested that the p38 signaling pathway is the major player in blocking the 
maturation of the autophagy process in senescent MCF-7/NeuT cells. The participation 
of the PI3K (class I)/AKT signaling pathway was not investigated because the available 
inhibitors are unspecific and block also class III PI3K, which are directly involved in 
autophagy.  
 
3.7 Mechanism underlying p38-mediated block of autophagy maturation 
 
In the previous section evidence for an impaired completion of autophagy in oncogene-
induced senescence via p38 was presented. The next goal of the work was to identify 
p38 targets involved in mediating the blockade of the autophagy flux. Based on the 
literature, we first considered several factors whose inactivation or deficiency leads to 
perturbed maturation of autophagic vacuoles. Then, we investigated whether they are 
controlled by the p38 signaling pathway. 
 
3.7.1 Cytoskeleton-mediated transport of autophagosomes (delivery of 
autophagosomes to lysosomes) is impaired in senescent cells via p38  
 
 3.7.1.1 Regulation of microtubule- associated protein activity by p38 
 
Microtubules facilitate both autophagosomal biogenesis and fusion of autophagosomes 
with lysosomes by trafficking of mature autophagosome (Webb et al., 2004). 
Microtubule stability and dynamics are regulated by microtubule-associated proteins. 
Two of these, the microtubule-associated protein 4 (MAP4) and stathmin/oncoprotein 18 
have recently been implicated in hypoxia-induced microtubule destabilization via p38 
(Hu et al., 2010). This report has shown that hypoxia induces microtubule 
depolymerization via the activation of the p38 signaling pathway and changes the 
phosphorylation levels of its downstream effectors, Map4 and op18. MAP4 binds to and 
stabilizes microtubules, however p38-mediated phosphorylation of MAP4 results in 
disassembly of microtubules (Hu et al., 2010). In contrast, STMN1/OP18 is a 
microtubule depolymeriser in its dephosphorylated state. While normally found 
Results 
 79 
inactivated as a phopho-protein, STMN1/OP18 dephosphorylation triggered by p38, 
destabilizes microtubules (Hu et al., 2010).  
 
In order to investigate whether a similar mechanism is involved in the senescence-
associated block of autophagy flux observed in our MCF-7/NeuT cell model, we first 
analyzed levels of MAP4 and STMN1/OP18 and their corresponding phosphorylated 
forms in the course of oncogene-induced senescence. As shown in Figure 38, MAP4 is 
phosphorylated in senescent cells. Vice versa oncoprotein 18 was dephosphorylated   
which predicts depolymerysation of microtubules. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 38: Destabilization of microtubules in senescent cells through phosphorylation of 
MAP4 and dephosphorylation of oncoprotein18. Representative western blot analysis for 
phosphorylated MAP4, total MAP4, phosphorylated Op18 and total Op18. ȕ-Actin was used as 
the loading control. 
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To explore the role of the p38 signaling pathway in the regulation of MAP4 and 
STMN1/OP18, we treated our cells with the p38 inhibitor SB203580. Our results 
showed dephosphorylation of MAP4 in senescent cells in presence of SB203580. On 
the other hand SB-mediated inhibition of p38 resulted in phosphorylation of oncoprotein 
18 similar to the control level. 
 
 
 
Figure 39: Destabilization of microtubules in senescence cells via the p38 signaling pathway. 
MCF-7/ NeuT cells were pre-incubated with the SB203580 inhibitor (20µM) 1 hr before dox treatment. 
Representative western blot analysis for phosphor MAP4, total MAP4, phosphor Op18 and total Op18. ȕ-
Actin was used as the loading control. 
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Staining of alpha-tubulin by immunofluorescence confirmed that the microtubule 
network is intact in pre-senescent but disrupted in senescent MCF-7/NeuT cells, as it 
was expected by the concomitant phosphorylation of MAP4 and the dephosphorylation 
of STMN1/OP18 that act as microtubule depolymerizers. Treatment of MCF-7/NeuT 
senescent cells (3d+dox) with vinblastine did not aggravate depolymerization, which 
supports the finding that microtubules are already affected in senescence. Inhibition of 
the p38 MAPK with SB203580 inhibitor results in apparently intact microtubule 
architecture, probably as a result of normal levels of dephosphorylated MAP4 and 
phosphorylated levels of STMN1/OP18. Additional treatment with vinblastine was 
shown to cause microtubule disruption again. 
 
 In conclusion, our results suggest that the microtubule network is compromised in 
senescence via p38 signaling (Fig-40). 
 
 
Results 
 82 
 
Figure 40: Disruption of the microtubule network in senescent MCF-7/NeuT cells via p38. Cells 
were subjected to dox-treatment at the indicated time points. Pre-incubation with SB203580 (20µM) was 
done for 1 hr before addition of dox. Vinblastine treatment was performed 2 h before fixation. Detection of 
the microtubule network was performed by immuno staining with an anti-Į-tubulin antibody. blue (DAPI), 
red (Į-tubulin) and green (EGFP). Images are representative of multiple images taken of each condition. 
Bar; 50 µm 
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3.7.1.2 Regulation of dynein light chain 1 (DYNLL1) expression by p38 
 
Microtubules facilitate autophagosome trafficking. Once formed, the autophagosome 
moves towards the lysosome along the microtubules by means of the dynein motors. 
Loss of dynein leads to an impairment of the clearance of aggregate-prone proteins by 
autophagy and to increased levels of LC3-II, reflecting a defect in the fusion between 
autophagosomes and lysosomes (Ravikumar et al., 2005). To determine the expression  
 
Figure 41: Down regulation of the dynein motor protein subunit DYNLL1 in senescence. A. 
Expression of dynein by qRT-PCR. The result presented here is the mean of three independent 
experiments, with error bars to represent standard deviations from mean. B. Western blot analysis of the 
dynein motor protein subunit DYNLL1. 
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level of dynein motor protein in senescent cells, a time-course study was performed 
from 0h to 14 days of dox treatment by using qRT-PCR to measure mRNA expression. 
Our result showed down regulation of the dynein motor protein subunit DYNLL1 (dynein 
light chain 1) upon NeuT induction. This result was confirmed at the protein level by 
immunoblotting using a specific antibody against DYNLL1. 
 
To further investigate whether p38 is the major signaling pathway responsible for down 
regulation of DYNLL1 we treated MCF7/NeuT cells with the SB inhibitor and analyzed 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 42. Down regulation of dynein motor protein subunit DYNLL1 by the p38 signaling 
pathway. MCF-7/NeuT cells were pre incubated with SB203580 inhibitor (20µM) 1 hr before dox 
treatment. A. Expression of dynein motor protein subunit DYNLL1 by qRT-PCR. The result presented is 
the mean of three independent experiments, with error bars to represent standard deviations. B. Western 
blot analysis for DYNLL1. 
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DYNLL1 both at mRNA and protein level. This results showed that the SB inhibitor can 
restore DYNLL1 expression, which coincided with restoration of the autophagic flux in 
senescence. 
 
 
3.7.2 Regulation of acidification and composition of lysosomes by p38 
pathway 
 
The late stage of autophagy depends on acidification and composition of lysosomes 
and lysosomal membranes and studies have shown that impairment of lysosomal 
function or biogenesis results in an accumulation of autophagosomes, which inevitably 
slows down or interrupts the autophagic flux. 
 
 
3.7.2.1 Down-regulation of cathepsin D expression by p38 signaling 
pathway in senescent cells 
 
Cathepsins are a major family of hydrolases that mediate protein degradation. They are 
synthesized as inactive precursors and are normally activated in the acidic environment 
of lysosomes. Previous published work described that reduced cathepsins cause 
impaired autophagic degradation (Tatti et al., 2012). 
 
 In order to explore this mechanism, we investigated cathepsin gene expression in 
senescence cells by RT-qPCR. Our result showed down-regulation of cathepsin D upon 
NeuT induction which was restored by SB inhibition. 
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Figure 43: Down regulation of cathepsin D in senescent cells via p38 signaling pathway. 
MCF-7/NeuT cells were pre incubated with SB203580 inhibitor (20µM) for 1 hr before dox 
treatment. The result is representative of three independent experiments, with error bars to 
represent standard deviations. 
 
 
3.7.2.2 The p38/MAPK pathway mediates down-regulation of the vacuolar 
ATPase  
 
Vacuolar ATPases (v-ATPases) are ubiquitous, multi-subunit proteins located in the 
cellular acidic compartment (endosomes, lysosomes). Their function is to transport 
protons across the vacuolar membrane by coupling ATP hydrolysis. Acidification of the 
vacuolar compartment is required to activate proteases necessary for degradation; 
therefore inhibition of v-ATPases impairs proteolysis. It has been proposed that an 
additional consequence of the inhibition of v-ATPase is the interruption of the 
autophagic flux, as determined by the inhibition of lysosomal degradation of autophagic 
cargo (Kinouchi et al., 2010).  
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In senescent cells expression of the v-ATPase was analyzed by qRT-PCR. We 
observed that the ATP6V0A2 subunit, a component of the V(0) domain of the V-ATPase 
that is involved in proton translocation, is reduced in senescent MCF-7/NeuT cells and 
that this down-regulation is triggered by the  p38 signaling pathway. 
 
 
Figure 44: p38 activation down regulated the vacuolar ATPase subunit ATP6V0A2. MCF-
7/ NeuT cells were pre incubated with SB203580 inhibitor (20µM) for 1 hr before time depended 
dox treatment. The result is representative of three individual experiments. Error bars represent 
standard deviations. 
 
In summary, multiple factors that are known to play a role in autophagy maturation were 
shown to be altered in senescence. In addition, it was shown that these factors are 
regulated by p38. This suggests that p38 provokes a blockade in autophagosome 
turnover by acting on multiple levels, including disruption of the microtubule network and 
of lysosomal functionality. 
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3.8 Attenuation of p38 by SB203580 in senescence rescues the microtubule 
network and restores the autophagy flux in a time-dependent manner 
 
The results above prompted us to investigate whether exposure of senescent cells to 
SB would revert the phenotypes observed. In contrast to previous experiments, we first 
induced senescence with dox and then applied SB203580 to MCF-7/NeuT senescent 
cells (3days+dox) in a time-dependent manner. This experiment showed that already 6h 
of SB203580 exposure lead to reduced vacuolization and after 24 hours cells were 
almost deprived from autophagic vesicles. 
 
 
Figure 45: Vacuolization in MCF-7/NeuT senescent cells is abolished by treatment with 
the SB203580 inhibitor. Cells were exposed to doxycycline (1µg/ml) for 3 days and then SB 
inhibitor (20 µM) was applied in a time dependent manner. Bar; 100 µm 
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Then we also checked whether SB203580 inhibition can rescue the expression of the 
autophagic marker LC3-II and the cargo protein p62. Our result showed lower levels of 
LC3-II and p62 expression indicating that the autophagy flux can be restored by 
SB203580.  
 
 
 
 
Figure 46: Effect of time-dependent SB inhibition of p38/MAPK pathway on LC3-II 
(autophagosomes) and p62 accumulation. Senescence cells were exposed to SB inhibitor 
(20 µM) at different time points and LC3 and p62 protein were analyzed by western blot 
technique. Į-Tubulin was used as the loading control. 
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In order to confirm that the reduction of LC3-II by SB203580 was not due to inhibition of 
autophagy but to restoration of the flux we applied vinblastine to 1h, 6h and 24h-SB-
treated cells. This lead to accumulation of LC3-II and p62 in the 6h and 24h-SB-treated 
cells, showing that SB had released the autophagy flux blockade and that vinblastine 
succeeded in blocking it. 
 
 
 
Figure 47: The p38 pathway negatively regulates autophagy and SB inhibitor restores 
autophagic flux. MCF-7/ NeuT cells were incubated with SB203580 (20µM) for 1hr, 6hr and 
24hrs. Before protein lysate extraction, cells were exposed for 2 hours to vinblastine (50µM). Į-
Tubulin was used as the loading control. 
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We further investigated the rescue effect of the SB203580 inhibitor on microtubule 
dynamics. Concomitant dephosphorylation of MAP4 and phosphorylation of OP18 was 
observed upon SB203580 treatment, suggesting that polymerization of microtubules 
and thus restoration of the p38-damaged microtubule network begin to occur when the 
p38 pathway becomes silenced 
 
 
 
Figure 48: Effect of SB inhibition of p38/MAPK pathway on MAP4 phosphorylation and 
Op18 dephosphorylation. Phosphorylated MAP4, total MAP4, phosphorylated Op18 and total 
Op18 were analyzed by Western blot. Į-Tubulin was used as the loading control. 
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For confirmation of the microtubule disruption and its restoration by SB203580 inhibitor 
we performed Į-tubulin immunofluorescence staining. Senescent cells showing 
microtubule disruption started to restore their microtubule network after 6h SB203580 
inhibitor and completely recovered it after 24hrs SB203580 treatment.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 49: SB inhibition of p38/MAPK pathway recued the tubulin formation. Cells were subjected to 
SB203580 (20µM) treatment at the indicated time points. Detection of the microtubule network was 
performed by immuno staining with red (Į-tubulin), blue (DAPI),and green (EGFP). Images are 
representative of multiple images taken of each condition. Bar; 10 µm 
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In summary, p38 activation during oncogene induced senescence promotes microtubule 
network disruption. This, in turn, is assumed to impair fusion between autophagosomes 
and lysosomes and results in accumulation of autophagosomes. SB203580 inhibitor is 
able to restore the microtubule network and to normalize the autophagic flux. 
 
 
3.8 p38 regulates the autophagy flux by a similar mechanism in other cell 
lines upon different kinds of stress  
 
Our results on the MCF7/NeuT cell line prompted us to investigate whether p38 
regulates the autophagy flux in other cell lines in a similar manner. For this purpose 
MCF-7, HeLa and HEK293 cells were treated with anysomycin, an inhibitor of protein 
synthesis that has previously been shown to trigger activation of the p38 MAPK 
pathway (Törocsik, 2000; Geiger, 2005).  
 
In MCF-7 proliferating cells, phophorylation of p38 is already clearly observed 30 
minutes after anysomycin exposure and increases considerably after 4 hours, reaching 
highest levels at 48 h exposure. This suggests that perseverance of stress conditions is 
reflected by stronger p38 signaling. Interestingly, levels of LC3-II became higher already 
after 6h whereas p62 started to accumulate only after 48h. 
 
Accumulation of both LC3-II and autophagic cargo after longer anisomycin treatment 
suggested again a blockade of the autophagic flux. This finding was confirmed by the 
LC3-II turnover assay with vinblastine treatment. In a similar manner than in NeuT 
oncogene-induced senescence (OIS) model, vinblastine was added for 2h at different 
time points of anisomycin exposure in order to block fusion of autophagosomes to 
lysosomes.  
 
Our results clearly show a bi-phasic behavior of the autophagy flux upon anisomycin 
treatment: induction of autophagy during 6h-24h anisomycin exposure and blockade of 
autophagy after longer exposure.  
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Figure 50: Activation of p38 signaling pathway and autophagosome formation by anisomycin. 
Proliferating MCF-7 were treated with anisomycin (10µM) for different time periods. Western blot analyses 
showing increased amounts of the autophagosome marker LC3-II and the cargo-adaptor protein p62 in 
senescent cells.  ȕ-Actin was used as the loading control. 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 51: Autophagy is impaired by sustained activation of the p38 signaling pathway. In the 
turnover assay, cells were treated with 50 µM of vinblastine for 2 hours before lysate extraction and LC3 
and p62 were analyzed by immunoblots. Į-Tubulin was used as the loading control. 
0       5       15      30       1        2        4        6   24      48     72
Phospho p38
Total p38
LC3 
ß-Actin
min hrs
p62
 
Results 
 95 
To determine the effect of the anisomycin-activated p38 signaling pathway in blockade 
of autophagy in MCF-7 cells, the LC3-II turnover assay was performed in presence or 
absence of the SB inhibitor. Two different time points of anisomycin exposure, 24h + 
anisomycin, representative for induction of autophagy and 3d+anisomycin, 
representative for blockade of the flux, were investigated. 
 
Our result showed that both induction of autophagy at 24h anisomycin exposure and 
blockade of autophagy maturation at 72 anisomycin exposure are mediated by p38. 
 
 
 
Figure 52: Sustained activation of p38 signaling pathway mediates blockade of autophagy.  MCF-7 
cells were pre-incubated with SB203580 (20µM) for 1 hr before time dependent anisomycin (10µM) 
treatment. Before protein lysate extraction cells were exposed for 2 hours to vinblastine (50µM). ȕ-Actin 
was used as the loading control. 
 
Next also LC3-puncta formation was analyzed and the influence of the p38 pathway on 
the levels of LC3-puncta was studied by confocal microscope images. The results of the 
LC3-II immunoblotting and immunofluorescence of LC3-puncta in the anisomycin 
(stress)-treated cells showed comparable results to those obtained in the oncogene 
induced senescence model. 
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Figure 53: Subcellular localization of LC3 puncta. MCF-7 cells were subjected to anisomycin (10µM) 
treatment at the indicated time points. Pre-incubation with SB203580 (20µM) was done for 1 hr before 
addition of anisomycin. Vinblastine treatment was performed 2 h before fixation. Detection of the LC3 
puncta was performed by immuno staining with an anti-LC3 antibody (red). The nuclei were labeled with 
DAPI (Blue). Images are representative of multiple images taken of each condition. Bar; 50 µm 
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This reinforces the idea that stress signals initially induce autophagy but that sustained 
activation of the p38 pathway by prolonged stress conditions finally lead to a block in 
autophagy maturation. As in the oncogene induced senescence model, the mechanism 
by which anisomycin leads to a defective autophagosome turnover was also 
investigated. We focused on the role of the microtubule network. We also found that 
exposure of cells to anisomycin for longer than 48h led to p38-dependent 
phosphorylation of MAP4 and dephosphorylation of STMN1/OP18 and that disruption of 
the microtubule network, as shown by immunofluorescence staining of alpha-tubulin, 
accompanied these events. 
 
 
 
Figure 54: Destabilization of microtubules in anisomycin treated MCF-7 cells. A. Western 
blot analysis for phosphorylated MAP4, total MAP4, phosphorylated Op18 and total Op18. B. 
Cells were pre-incubated with the SB203580 inhibitor (20µM) 1 hr before anisomycin treatment. 
ȕ-Actin was used as the loading control. 
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Figure 55: Disassembly of the microtubule network in MCF-7 cells via p38. Cells were subjected to 
treatment at the indicated time points. Pre-incubation with SB203580 (20µM) was done for 1 hr before 
anisomycin. Vinblastine (50 µM) treatment was performed 2 h before fixation. Detection of the 
microtubule network was performed by immuno staining with Į-tubulin (red), DAPI (blue). Images are 
representative of multiple images taken of each condition. Bar; 50 µm 
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Next we again analyzed the expression level of the dynein motor protein subunit 
DYNLL1 in anisomycin model. Our result showed the down regulation of dynein protein 
after 72 hours anisomycin incubation when the autophagic flux was impaired. This 
reduced protein level is also triggered by p38 signaling pathway.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 56: Down regulation of dynein motor protein subunit DYNLL1 by sustained activation of the 
p38 signaling pathway. Proliferating MCF-7 were treated with anisomycin (10µM) for different time 
periods and  dynein motor protein subunit DYNLL1 was analyzed by westernblot. Į-Tubulin was used as 
the loading control 
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In order to find out whether this mechanism is also operating in other cell lines in 
addition to breast cancer MCF-7 cells we performed the same set of experiments in 
HEK293 and HeLa cells. Anisomycin treatment of these two cell lines also activated the 
p38 pathway and led to the previously described biphasic behaviour in the autophagy 
flux.  
Figure 57: Autophagy maturation is impaired in HEK and HeLa cells by sustained 
activation of the p38 signaling pathway. A. Hela. B. HEK293.  Cells were pre-incubated with 
SB203580 (20µM) for 1 hr before time dependent anisomycin (10µM) treatment. In the LC3 turn over 
assay, cells were exposed for 2 hours to vinblastine (50µM) before protein lysate extraction. ȕ-Actin was 
used as the loading control. 
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Moreover, the phosphorylation of MAP4 and dephosphorylation of Op18 by p38 also 
proved to be involved in these two additional cell lines.  
 
 
 
 
Figure 58: p38-MAPK-triggered autophagy flux blockade occurs via disruption of the microbule 
network. Cells were pre-incubated with the SB203580 inhibitor (20µM) 1 hr before anisomycin treatment. 
Western blot analysis for phosphorylated MAP4, total MAP4, phosphorylated Op18 and total 
Op18. ȕ-Actin was used as the loading control. 
 
 
In conclusion, the p38-mediated block of autophagy maturation happens in different 
contexts and cell lines in response to persistent stress conditions. 
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3.9 Biological consequences of the blockade in the autophagy flux  
 
At present, the exact role of autophagy is highly controversial. Autophagy generally 
serves as a cell survival mechanism under stress conditions. Many recent studies have 
shown the cytoprotective role of autophagy in mammalian cells. Paradoxically, 
autophagy has also been implicated in cell death, called autophagic or type II 
programmed cell death. To determine the relationship between autophagy and cell 
survival in senescent cells we monitored cleavage of the PARP, poly (ADP-ribose) 
polymerase by westernblot. Cleavage of PARP facilitates cellular disassembly and 
serves as a marker of cells undergoing apoptosis. Our result showed that in general 
senescent cells were resistance to PARP cleavage although we found cleavage at very 
late stage of senescence (14d+dox). This indicates that blockage of the autophagy flux 
during senescence does not compromise the survival ability of the cells. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 59: PARP cleavage in senescent cells. A. cells were analyzed for PARP cleavage by western 
blot analysis. B. Cells were pre-incubated with the SB203580 inhibitor (20µM) 1 hr before dox treatment 
and analyzed by western blot.  
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We also monitored PARP cleavage in our anisomycin model. After 24 hours incubation 
with anisomycin, when the autophagic flux was induced, no PARP cleavage was 
detected. However, PARP cleavage occurred when autophagy was impaired after 
longer anisomycin treatment. Because several studies have been shown that 
anisomycin is an apoptosis inducer in many cell types, we hypothesized that PARP 
cleavage in MCF-7 and HEK cells might be the p38-independent toxic effect of 
anisomycin. However, exposure of cells to the p38 inhibitor SB abolished PARP 
cleavage, demonstrating the role for the p38 pathway in promoting apoptosis after 
longer periods of anisomycin exposure. 
Figure 60: PARP cleavage in anisomycin treated cells. PARP cleavage was analyzed by 
Western blot in MCF-7 and Hek cells. B. Cells were pre-incubated with the SB203580 inhibitor 
(20µM) 1 hr before anisomycin (10µM) treatment. 
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4.0 Discussion 
4.1 Role of p38 in autophagy in oncogene induced senescence cells 
It is well acknowledged that p38 plays a key role in autophagy regulation (Tang et al., 
2008; Webber and Tooze, 2010; Keil et al., 2012; Mei et al., 2012; Choi et al., 2010; 
Moruno-Manchon et al., 2013; Vom Dahl et al., 2001; Homer et al., 2012; Paillas et al., 
2012). However, a currently unresolved discrepancy is that approximately half of all 
publications adressing this question report a positive (Table-8), whereas the other half 
found an inhibitory influence of p38 on autophagy (Table-9). Negative feedback 
regulation of mTOR has been suggested as a possible mechanism of positive 
autophagy regulation by p38 (Tang et al., 2008), while compromised autophagosome 
formation (Webber and Tooze, 2010), maturation (Keil et al., 2012), downregulation of 
ULK1 (Mei et al., 2012) and microtubule disruption (Haussinger et al., 1999) may 
explain the negative influence on the autophagic flux. However, an explanation of the 
discrepancy (positive but also negative regulation by the same signaling pathway) is not 
possible considering the current literature. In order to bridge this gap, the question 
addressed in this work was how p38 regulates autophagy during the time-course of 
exposure to a stress stimulus. 
First we applied a cell model of oncogene-induced senescence, where an oncogenic 
variant of ERBB2 (NeuT) can be inducibly expressed (Trost et al., 2005; Spangenberg 
et al., 2006; Cadenas et al., 2010; 2012). In this cell system NeuT expression leads to 
permanent p38 activation up to the longest studied time period of 14 days. We observed 
an early (24h) induction of the autophagic flux in contrast to a late inhibition (3-14 days). 
To test another stress stimulus besides NeuT overexpression, we used the protein 
synthesis inhibitor anisomycin (that is able to activate stress-activated kinases 
independently of its ability to block protein synthesis). Also anisomycin provoked an 
early induction and late inhibition of the autophagic flux. Both effects (induction and 
inhibition) could be reversed by the p38 inhibitor SB. The results could be reproduced in 
three different cell lines (MCF-7, HeLa and HEK293). It is important to note that in order 
to verify the effects of p38 on the autophagy flux both LC3-II and p62 levels were 
systematically analyzed in combination with the flux inhibitors vinblastine and 
bafilomycin A1, according to the proposed guidelines (Klionsky, DJ et al., 2008). In 
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addition, Western blot-based LC3-II turnover assays were in good agreement with the 
imaging of the LC3-punctae. 
 
4.2  A  model for regulation of autophagy by p38 
 
The results obtained in this work show both p38-induced enhancements as well as 
inhibition of the autophagic flux. An important aspect is the duration and intensity of p38 
activation. Therefore, in the model proposed (Fig-61) low or transitory stress conditions 
that moderately activate p38 stimulate the autophagic flux.  
 
Figure 61: Proposed model for the role of p38 in autophagy. This model takes into 
account the duration and intensity of p38 activity. Low or transitory stress conditions that 
moderately activate p38 stimulate the autophagic fluy by inducing early steps of the 
autophagic process. In contrast, more permanent and intensive stress that causes a 
strong activation of p38 blocks the autophagic flux at the maturation step. 
In contrast, more permanent and intensive stress that causes a strong activation of p38 
blocks the autophagic flux. The principle that short-term activation of p38 stimulates 
autophagy whereas long-term activation blocks it was confirmed in different cell systems 
Time course/ intensity of p38 activation
Induction of 
autophagy Block of autophagymaturation
threshold
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under stress stimuli, as mentioned above. The molecular mechanisms by which p38 
was found to exert these effects are discussed in the following sections. 
 
4.3 Mechanism of late block of autophagy by p38 
The block of the autophagic flux is the more prominent phenomenon observed in this 
work. It could be shown that this block is accompanied by a compromised microtubule 
network (Fig-38 in Results). In addition it was found that modulating the phosphorylation 
status of the microtubule associated proteins MAP4 and STMN1/OP18 is one important 
mechanism by which p38 controls microtubule dynamics (Fig-62 in Discussion and Fig-
39 in Results). Accordingly, p38-mediated microtubule depolymerization involves 
phosphorylation and thus inactivation of the microtubule stabilizing protein MAP4 and 
concomitant dephosphorylation followed by activation of the microtubule de-stabilizing 
protein STMN1/OP18.  
 
The roles of the microtubule network and of the dynein motor protein complex in 
autophagy have been investigated in numerous studies (Fass et al., 2006; Jahreiss, L. 
et al., 2008; Kochl, R. et al., 2006; Webb, J.L. 2004; Ravikumar, B et al., 2005; Kimura 
S. et al., 2008). It has also been shown that p38MAPK can modulate cytoskeleton 
dynamics by directly regulating microtubule associated proteins (Hu J.Y. et al., 2010). 
But this study is, to the best of our knowledge, the first one to recognize that p38 affects 
autophagosome maturation by compromising microtubule stability and downregulating 
motor proteins. This study suggests also for the first time that MAP4 and STMN1/OP18 
can influence the autophagy flux via their their microtubule assembly-disassembly 
properties.  
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In addition to these p38-triggered post-translational modifications of MAPS, also a ”late 
stage” p38-dependent downregulation of the dynein motor subunit DYNLL1 at both 
gene and protein levels was observed in our senescence model and confirmed in the 
anisomycin model. Regulation of DYNLL1 expression by p38 had never been reported 
before and thus it represents a novel mechanism of regulating autophagy. 
 
Figure 62: Mechanism by which p38 leads to a blocked autophagic flux. P38 
signaling dephosphorylates, and thus activates the microtubule depolymerizer 
OP18/STMN1; it phosphorylates MAP4 provoking its detachment from microtubules and 
their subsequent destablization and it downregulates expression of dynein subunits, 
such as DYNLL1. These events impair trafficking of autophagosomes 
 
Since both microtubules and the dynein motor complex have been shown to be involved 
in autophagosome trafficking to the lysosome (Ravikumar, B et al., 2005; Kimura S. et 
al., 2008), the afore-mentioned events lead to impaired autophagosome-lysosome 
fusion. Thus, the demonstrated late stage after p38 activation characterized by blocked 
autophagic flux is a consequence of impaired trafficking via microtubules. Other p38-
mediated alterations in gene expression observed in this study such as downregulation 
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of the cathepsin D and lysosomal vacuolar ATPase subunit ATP6VOA2  (Fig-43 and 
Fig- 44 in result part) are also bond to play an important role in inhibiting the autophagic 
flux by compromising lysosomal activity. This suggests that p38 signaling directs 
inhibition autophagy by acting on a multitude of downstream substrates. 
 
4.4 Mechanism of early induction of autophagy by p38 
Further studies will be required to identify the specific mechanisms used by p38 to 
positively regulate autophagy induction under low-stress conditions. Interestingly, p38 
has been predicted to phosphorylate ULK1 (Mack et al., 2012) at a consensus p38 
phosphorylation site. Unfortunately, no antibody that specifically recognizes this putative 
p38-phosphorylation site is commercially available up to date. It is also noteworthy that 
DYNLL1 has been implicated in a recent study in the control of autophagosome 
formation (Di Bartolomeo, S.D. et al., 2010). The authors could show that the interaction 
between DYNLL1/2 and the Beclin1-interacting protein AMBRA1 keeps the Beclin1-
Vps34 complex attached to the cytoskeleton. Induction of autophagy releases the 
AMBRA1-Beclin1-Vps34 complex from dynein and enables its localization to the 
endoplasmatic reticulum where autophagosome formation is thought to occur. 
Moreover, the same study showed that knockdown of DYNLL1 resulted in enhanced 
LC3 lipidation. This prompted us to hypothesize p38-mediated downregulation of 
DYNLL1 as a possible mechanism to induce autophagy. However, decreased levels of 
DYNLL1 in our experimental models are only observed at late stages of p38 activation, 
when autophagy is impaired. Therefore, this mechanism can not be responsible for the 
initial induction of autophagy. 
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Figure 63: Possible mechanism by which p38 may induce autophagy (this is a 
speculation). p38 could phosphorylate ULK1, which is essential for induction of 
autophagy by promoting assembly of the AMBRA1-Bcl2-Vps34 complex and 
autophagosome formation. 
 
4.5 Does p38 regulate autophagy in other stress/pathological conditions by 
a similar mechanism? 
 
The results obtained by both experimental models in different cell lines suggest a 
general role of the p38 MAPK-cytoskeleton axis in the negative regulation of late steps 
of autophagy. Interestingly, in several neurodegenerative diseases that are 
characterized by an impaired autophagy flux and accumulation of autophagosomes/ 
autolysosomes (Alzheimer disease, AD, Parkinson disease, PD) there is evidence for 
p38 playing a role in the pathophysiology of disease. One of the suggested functions of 
p38 in AD is phophorylation of tau (MAPT), which is a neuron-specific microtubule-
associated protein with a similar function in microtubule dynamics as MAP4. 
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Hyperphophorylated tau causes its aggregation and therefore compromises 
microtubule-dependent axonal transport (Shahpasand el al., 2012). Pharmacological 
inhibition of p38 has been shown to alleviate the pathophysiology of the disease. 
However the underlying mechanisms remain to be elucidated. In light of our results, it 
could be plausible that p38-mediated phosphorylation of tau leads to AD-associated 
impaired autophagic clearance via destabilization of microtubules. In this case we would 
assume that p38-inhibition releases the blockade of autophagy in neurodegenerative 
diseases. This requires further investigation. 
  
4.5 Biological consequences of impaired autophagy 
 
Autophagy is believed to support cellular metabolism and cell survival under starvation 
and stress conditions. Many studies have reported a cytoprotective role of autophagy in 
mammalian cells (Wang et al., 2012; Tu et al., 2012; Moreau et al., 2010). On the other 
hand, autophagy has also been implicated in cell death, either directly by the so called 
autophagic or type II programmed cell death (Clarke, 1990; Kroemer et al., 2005; 
Bursch et al., 2001; Tsujimoto, 2005) or through its crosstalk with apoptosis (Salminen, 
A et al., 2012; Shi, M et al., 2012; Rikiishi, 2012), suggesting that excessive autophagy 
can also be detrimental. Our findings that compromised autophagy maturation is 
accompanied by apoptosis (observed in 3d anysomycin-treated cells and in 14 days 
senescent cells) are consistent with a cytoprotective role of autophagy. An intriguing 
observation was the late onset of apoptosis in the oncogene-induced senescence 
model. Here we observed PARP cleavage only after a relatively long period of blocked 
autophagy (14 days), whereas in the anisomycin model apoptosis became evident 
much earlier (Fig-59 and Fig-60). 
 
Having demonstrated the biphasic nature of a p38-controlled autophagic flux its 
possible biological significance should be addressed. The consequences of initially 
induced autophagy are obvious. Initial stress sensors activate the well-known stress 
activated pathway p38 which in turn facilitates the removal of damaged cell components 
by increased autophagic flux. As already discussed by others, this supports cell survival  
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(Bernales et al., 2006; Ostenfeld et al., 2008; Iwata et al., 2006). In this context it is of 
interest that p38 but not its sister stress pathway JNK plays a role in regulation of 
autophagy in MCF-7/NeuT cells. The explanation of the biological implications of 
blocked autophagy maturation after permanent p38 is much more difficult. One may 
expect that upon permanent stress, reflected by continuous p38 activation, the cell 
actively directs its fate towards cell death. On the other hand, the late block of 
autophagy may also serve a protective purpose. Two aspects in this scenario may be 
important: i) Blocking fusion of autophagosomes with lysosomes might be cytoprotective 
in situations in which excess of autophagy compromises the integrity of lysosomes 
(Pivtoraiko et al., 2009) ii) these cells may develop alternative mechanisms for 
clearance of cell damage in order to survive. A completely different explanation would 
be that it may be an advantage for an organism to remove cells by apoptosis that have 
experienced high levels of prolonged stress. The described autophagy block upon long 
term P38 activation may contribute to the cell’s decision to undergo active cell death. 
 
4.6 Role of autophagy in senescence 
The relationship between autophagy and senescence has been previously investigated 
in a model of oncogenic Ras-induced senescence (Young et al., 2009) in IMR90 cells. 
In this experimental model autophagy was shown to be induced during the transition 
from the mitotic to the senescent state. Moreover, autophagy was shown to be essential 
for the establishment of senescence. In our study we also observed initial induction of 
autophagy upon oncogenic ERBB2 expression, however attenuation of the autophagic 
flux occurs simultaneously with the onset of senescence. In previous work with our 
MCF-7/NeuT cell line it was found that p38-mediated activation/upregulation of p21 is 
responsible for the establishment of senescence. Since in the current study p38 was 
found to negatively regulate autophagy, we assume that this negative effect of p38 on 
autophagy is part of the anti-tumor/fail-safe mechanism senescence is considered to be. 
This is in agreement with the classical view that autophagic activity decreases during 
aging and that the impaired autophagic clearance contributes to the aging-related 
accumulation of cellular damage. 
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In conclusion, in this work it could be shown that transient p38 activation causes 
enhanced autophagic flux whereas permanent p38 signaling blocks autophagy by 
compromising microtubule-mediated transport. This study demonstrates the importance 
of considering dynamics and kinetics of p38 activation to understand its importance on 
autophagy. 
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Tabel 8: p38 as positive regulator of autophagy 
Reference Stimulus Cell line Statement/ Proposed 
mechanism 
Methode employed 
to investigate p38 
role 
Methode emplyed to 
detect autophagy 
Tang et al., 2008 Accumulation of 
GFAP  
U251 astrocytoma 
cells overexpressing 
GFAP 
p38 becomes 
phosphorylated upon 
GFAP accumulation and 
induces autophagy via 
inhibition of  mTOR  
Pharmacological 
inhibition of p38 
with SB 203580 
 
Knockdown with 
p38 siRNA 
LC3-II/LC3-I ratio by 
immunoblotting  
Choi et al., 2010 Capsaicin exposure MCF-7 and MDA-
MB231 breast cancer 
cell lines 
p38 becomes activated 
upon capsaicin 
exposure and induces 
autophagy by positively 
regulating the 
sequestration step 
  
Homer et al., 2012 Muramyl dipeptide 
(MDP) 
HCT116 human 
colorectal 
adenocarcinoma 
Autophagy induction 
requires p38 
Pharmacological 
inhibition of p38 
with SB 203580 
 
Knockdown with 
p38 siRNA 
 
Paillas et al., 2012 SN-38 (the active 
metabolite of 
irinotecan) 
HCT116 human 
colorectal 
adenocarcinoma 
p38 becomeas activated 
upon SN-38 exposure 
and induces autophagy 
  
Moruno-Manchon et 
al., 2013 
Addition of  glucose 
under starvation 
conditions 
NIH/3T3, MEFs p38 becomes activated 
upon glucose exposure 
and induces autophagy 
Pharmacological 
inhibition of P38 
with SB 203580 
 
Knockdown with 
p38 siRNA 
LC3-II levels  +/- 
NH4Cl and 
Leupeptin by 
immunoblotting 
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Table 9: p38 as a negative regulator of autophagy 
 
Reference Stimulus Cell line Proposed 
mechanism 
Method employed 
to investigate p38 
role 
Method employed 
to detect autophagy 
Haussinger et al., 
1999 
Swelling induced by  
hypoosmolarityor 
glutamine, ethanol, or 
insulin 
Rat hepatocytes p38 becomes 
activated by  hypo-
osmotic live perfusion 
and leads to a 
decrease in cell 
proteolysis and 
inhibition of 
autophagic vacuole 
formation 
Pharmacological 
inhibition of p38 with 
SB203580 
Proteolysis 
Vom Dahl et al, 2001 
 
Swelling by 
hypoosmolarity 
Rat hepatocytes p38 becomes 
activated by  hypo-
osmotic live perfusion 
and leads to a 
decrease in 
autophagic vacuoles 
in a microtubule-
dependent manner 
Pharmacological 
inhibition of p38 with 
SB203580 
Quantification of 
volume of autophagic 
vacuoles 
Weber and Tooze 
2010 
Starvation HEK293 Phosphorylated 
p38alpha leads to 
inhibition of 
autophagy through 
sequestering of 
p38IP, which is 
required for  mAtg9 
trafficking and thus 
autophagosome 
formation 
Overexpression of 
p38alpha 
LC3-II/LC3-I  ratio +/- 
Leupeptin 
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Keil et al., 2012 Overexpression of 
Gadd45ȕ +/- 
Starvation 
NIH3T3 p38 becomes 
targeted to 
autophagosomes by 
Gadd45ȕ/MEKK4 
and inhibits fusion to 
lysosomes via 
phosphorylation of 
Atg5 
  
Mei et al., 2012 Cholesterol loading 
with LDL 
Macrophage cell line 
THP1 
p38 becomes 
phosphorylated upon 
LDL loading and 
inhibits  induction of 
autophagy by 
downregulating ULK1 
expression 
Pharmacological 
inhibition of P38 with 
SB 203580 
 
Knockdown with p38 
siRNA 
LC3-II/LC3-I ratio by 
immunoblotting  
 
GFP-LC3 dot 
formation by 
fluorescence 
microscopy 
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